Aebersold H, Foster-Witassek F, Aeschbacher S, Beer JH, Blozik E, Blum M, Bonati L, Conte G, Coslovsky M, De Perna ML, Di Valentino M, Felder S, Huber CA, Moschovitis G, Mueller A, Paladini RE, Reichlin T, Rodondi N, Stauber A, Sticherling C, Szucs TD, Conen D, Kuhne M, Osswald S, Schwenkglenks M*, Serra-Burriel M*; Swiss-AF Investigators. Patients on vitamin K treatment: is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohort. Open Heart. 2024;11:e002567. doi: 10.1136/openhrt-2023-002567.
https://pubmed.ncbi.nlm.nih.gov/38302139/
* Shared last authorship.

Favre-Bulle A, Huang M, Haiderali A, Bhadhuri A. Cost-Effectiveness of Neoadjuvant Pembrolizumab plus Chemotherapy Followed by Adjuvant Pembrolizumab in Patients with High-Risk, Early-Stage, Triple-Negative Breast Cancer in Switzerland. Pharmacoecon Open 2024;8:91-101. doi: 10.1007/s41669-023-00445-8.
https://pubmed.ncbi.nlm.nih.gov/37999854/

Stoffel, S. T., Chaki B., & Vlaev, I. (2024). Testing a decoy donation incentive to improve online survey participation: Evidence from a field experiment. PLoS ONE 19(2): e0299711. https://doi.org/10.1371/journal.pone.0299711

Parisi, I., Hosea, A. V., Stoffel, S., Nemec, M., Badat, S., Seward, E., Kaushal, A., Kerrison, R., & Von Wagner, C. (2024). Evaluation of the safety, efficacy and feasibility of ‘at-home’capsule endoscopy. Frontline Gastroenterology. https://doi.org/10.1136/flgastro-2023-102565

Stoffel, S. T., Law, J. H., Kerrison, R., Brewer, H. R. , Flanagan, J. M. , Hirst, Y. (2024). Testing the Effectiveness of Behavioural Messages on Twitter to Increase Health Research Recruitment Using Social Media Campaigns on Twitter: A Web-based Experiment. JMIR Formative Research, e48538. https://doi.org/10.2196/48538

Meier, N., Fuchs, H., Galactionova, K., Hermans, C., Pletscher, M., & Schwenkglenks, M. (n.d.). Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Versus Extended Half-Life Prophylaxis for Moderate-to-Severe Haemophilia B in Germany. PharmacoEconomics - Open. doi: https://doi.org/10.1007/s41669-024-00480-z

Gut, S., Rauch, M., Haschke, M., Huber, C. A., Gaertner, J., Schur, N., Meier, C. R., Spoendlin, J. (2024) Use of metamizole and other non-opioid analgesics in Switzerland between 2014 and 2019: an observational study using a large health insurance claims database. Swiss Med Wkly, 154:3535. https://doi.org/10.57187/s.3535

Zay Ya K, Win PTN, Bielicki J, Lambiris M*, Fink G*. Association Between Antimicrobial Stewardship Programs and Antibiotic Use Globally: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2023 Feb 1;6(2):e2253806. doi: 10.1001/jamanetworkopen.2022.53806.
https://pubmed.ncbi.nlm.nih.gov/36757700/
 * Shared last authorship.
 

Lambiris MJ, Venga GN, Ssempala R, Balogun V, Galactionova K, Musiitwa M, Kagwire F, Olosunde O, Emedo E, Luketa S, Sangare M, Buj V, Delvento G, Tshefu A, Okitawutshu J, Omoluabi E, Awor P, Signorell A, Hetzel MW, Lee TT, Brunner NC, Cereghetti N, Visser T, Napier HG, Burri C, Lengeler C. Health system readiness and the implementation of rectal artesunate for severe malaria in sub-Saharan Africa: an analysis of real-world costs and constraints. Lancet Glob Health. 2023 Feb;11(2):e256-e264. doi: 10.1016/S2214-109X(22)00507-1.
https://pubmed.ncbi.nlm.nih.gov/36565705/
 

Hetzel MW, Okitawutshu J, Tshefu A, Omoluabi E, Awor P, Signorell A, Kwiatkowski M, Lambiris MJ, Visser T, Cohen JM, Buj V, Burri C, Lengeler C. Pre-referral rectal artesunate is no "magic bullet" in weak health systems. BMC Med. 2023 Mar 30;21(1):119. doi: 10.1186/s12916-023-02777-y. PMID: 36991404; PMCID: PMC10060914.
pubmed.ncbi.nlm.nih.gov/36991404/
 

Hetzel MW, Awor P, Tshefu A, Omoluabi E, Burri C, Signorell A, Lambiris MJ, Visser T, Cohen JM, Buj V, Lengeler C. Pre-referral rectal artesunate: no cure for unhealthy systems. Lancet Infect Dis. 2023 Jun;23(6):e213-e217. doi: 10.1016/S1473-3099(22)00762-9. Epub 2022 Dec 19.
pubmed.ncbi.nlm.nih.gov/36549311/
 

Brunner NC, Karim A, Athieno P, Kimera J, Tumukunde G, Angiro I, Signorell A, Delvento G, Lee TT, Lambiris M, Ogwal A, Nakiganda J, Mpanga F, Kagwire F, Amutuhaire M, Burri C, Lengeler C, Awor P, Hetzel MW. Starting at the community: Treatment-seeking pathways of children with suspected severe malaria in Uganda. PLOS Glob Public Health. 2023 Jul 5;3(7):e0001949. doi: 10.1371/journal.pgph.0001949.
https://pubmed.ncbi.nlm.nih.gov/37405978/
 

Barbier MC, Fengler A, Pardo E, Bhadhuri A, Meier N, Gautschi O. Cost Effectiveness and Budget Impact of Nivolumab Plus Ipilimumab Versus Platinum Plus Pemetrexed (with and Without Bevacizumab) in Patients with Unresectable Malignant Pleural Mesothelioma in Switzerland. Pharmacoeconomics 2023;41:1641-1655. doi: 10.1007/s40273-023-01305-3.
https://pubmed.ncbi.nlm.nih.gov/37572261/

Meinlschmidt G, Frick A, Baenteli I, Karpf C, Studer A, Bachmann M, Dörner A, Tschudin S, Trost S, Wyss K, Fink G, Schwenkglenks M, Caviezel S, Rocco T, Schaefert R; SomPsyNet consortium. Prevention of psychosocial distress consequences in somatic hospital inpatients via a stepped and collaborative care model: protocol of SomPsyNet, a stepped wedge cluster randomised trial. BMJ Open 2023;13:e076814. doi: 10.1136/bmjopen-2023-076814.
https://pubmed.ncbi.nlm.nih.gov/37996236/

Foster-Witassek F, Aebersold H, Aeschbacher S, Ammann P, Beer JH, Blozik E, Bonati LH, Cattaneo M, Coslovsky M, Felder S, Moschovitis G, Müller A, Netzer S, Paladini RE, Reichlin T, Rodondi N, Stauber A, Sticherling C, Szucs T, Conen D, Kühne M, Osswald S, Serra-Burriel M, Schwenkglenks M; Swiss‐AF Investigators. Longitudinal Changes in Health-Related Quality of Life in Patients With Atrial Fibrillation. J Am Heart Assoc 2023;12:e031872. doi: 10.1161/JAHA.123.031872.
https://pubmed.ncbi.nlm.nih.gov/37929709/

Serra-Burriel M, Aebersold H, Foster-Witassek F, Coslovsky M, Rodondi N, Blum MR, Sticherling C, Moschovitis G, Beer JH, Reichlin T, Krisai P, Aeschbacher S, Paladini RE, Kühne M, Osswald S, Conen D, Felder S, Schwenkglenks M, for the Swiss-AF investigators. Real-world cost-effectiveness of pulmonary vein isolation for atrial fibrillation: a target trial approach. Value Health 2023;26:1721-1729. doi: 10.1016/j.jval.2023.08.008.
https://pubmed.ncbi.nlm.nih.gov/37741443/

Aebersold H, Foster-Witassek F, Serra-Burriel M, Brüngger B, Aeschbacher S, Beer JH, Blozik E, Blum MR, Bonati LH, Conen D, Conte G, Felder S, Huber C, Kühne M, Moschovitis G, Müller A, Paladini R, Reichlin T, Rodondi N, Springer A, Stauber A, Sticherling C, Szucs T, Osswald S, Schwenkglenks M, on behalf of the Swiss-AF Investigators. Estimating the cost impact of atrial fibrillation using a prospective cohort study and population-based controls. BMJ Open 2023;13:e072080. doi: 10.1136/bmjopen-2023-072080.
https://pubmed.ncbi.nlm.nih.gov/37709325/

Aebi NJ, Baenteli I, Fink G, Meinlschmidt G, Schaefert R, Schwenkglenks M, Studer A, Trost S, Tschudin S, Wyss K; SomPsyNet Consortium. Facilitators and barriers of routine psychosocial distress assessment within a stepped and collaborative care model in a Swiss hospital setting. PLoS One 2023;18:e0285395. doi: 10.1371/journal.pone.0285395.
https://pubmed.ncbi.nlm.nih.gov/37390066/

Stoffel ST, Schwenkglenks M, Mutschler T. General Practitioners' Awareness and Perception of Current Pneumococcal Vaccination for Adult Patients with Known Risk Factors in Switzerland: Evidence from a Survey. Vaccines (Basel) 2023;11:1101. doi: 10.3390/vaccines11061101.
https://pubmed.ncbi.nlm.nih.gov/37376490/

Pinsent A, Weston G, Adams EJ, Linley W, Hawkins N, Schwenkglenks M, Hamlyn-Williams C, Toward T. Determining the Relationship Between Seizure-Free Days and Other Predictors of Quality of Life in Patients with Dravet Syndrome and Their Carers from FFA Registration Studies. Neurol Ther 2023;12:1593-1606. doi: 10.1007/s40120-023-00510-8.
https://pubmed.ncbi.nlm.nih.gov/37328668/

Moutzouri E, Glutz M, Abolhassani N, Feller M, Adam L, Gencer B, Del Giovane C, Bétrisey S, Paladini RE, Hennings E, Aeschbacher S, Beer JH, Moschovitis G, Seiffge D, De Marchis GM, Coslovsky M, Reichlin T, Conte G, Sinnecker T, Schwenkglenks M, Bonati LH, Kastner P, Aujesky D, Kühne M, Osswald S, Fischer U, Conen D, Rodondi N. Association of statin use and lipid levels with cerebral microbleeds and intracranial hemorrhage in patients with atrial fibrillation: A prospective cohort study. Int J Stroke 2023:17474930231181010. doi: 10.1177/17474930231181010.
pubmed.ncbi.nlm.nih.gov/37243540/

Jungo KT, Ansorg AK, Floriani C, Rozsnyai Z, Schwab N, Meier R, Valeri F, Stalder O, Limacher A, Schneider C, Bagattini M, Trelle S, Spruit M, Schwenkglenks M, Rodondi N, Streit S. Optimising prescribing in older adults with multimorbidity and polypharmacy in primary care (OPTICA): cluster randomised clinical trial. BMJ 2023;381:e074054. doi: 10.1136/bmj-2022-074054.
https://pubmed.ncbi.nlm.nih.gov/37225248/

Sibille FX, de Saint-Hubert M, Henrard S, Aubert CE, Goto NA, Jennings E, Dalleur O, Rodondi N, Knol W, O'Mahony D, Schwenkglenks M, Spinewine A. Benzodiazepine Receptor Agonists Use and Cessation Among Multimorbid Older Adults with Polypharmacy: Secondary Analysis from the OPERAM Trial. Drugs Aging 2023;40(6):551-561. doi: 10.1007/s40266-023-01029-1.
pubmed.ncbi.nlm.nih.gov/37221407/

Roos J, Schürch D, Frei A, Lagger S, Schwenkglenks M, Vogt A, Herzig D, Bally L. Time requirements for perioperative glucose management using fully closed-loop versus standard insulin therapy: A proof-of-concept time-motion study. Diabet Med 2023:e15116. doi: 10.1111/dme.15116.
https://pubmed.ncbi.nlm.nih.gov/37052409/

Salari P, Henrard S, O'Mahony C, Welsing P, Bhadhuri A, Jungo KT, Beck T, O'Mahony D, Byrne S, Spinewine A, Knol W, Rodondi N, Schwenkglenks M. Healthcare Costs and Health-Related Quality of Life in Older Multimorbid Patients After Hospitalization. Health Serv Insights 2023;16:11786329231153278. doi: 10.1177/11786329231153278.
pubmed.ncbi.nlm.nih.gov/36760460/

Favre-Bulle A, Bencina G, Zhang S, Jiang R, Andritschke D, Bhadhuri A. Cost-effectiveness of pembrolizumab as an adjuvant treatment for patients with resected stage IIB or IIC melanoma in Switzerland. J Med Econ 2023;26:283-292. doi: 10.1080/13696998.2023.2174748. PMID: 36748342 Free article.
https://pubmed.ncbi.nlm.nih.gov/36748342/

Aebersold H, Serra-Burriel M, Foster-Wittassek F, Moschovitis G, Aeschbacher S, Auricchio A, Beer JH, Blozik E, Bonati LH, Conen D, Felder S, Huber CA, Kuehne M, Mueller A, Oberle J, Paladini RE, Reichlin T, Rodondi N, Springer A, Stauber A, Sticherling C, Szucs TD, Osswald S, Schwenkglenks M. Patient clusters and cost trajectories in the Swiss Atrial Fibrillation cohort. Heart 2023:109:763-770. doi: 10.1136/heartjnl-2022-321520.
https://pubmed.ncbi.nlm.nih.gov/36332981/

Stoffel, S. T., Sun, Y., Hirst, Y., von Wagner, C., Vlaev, I. (2023). Testing the decoy effect to improve online survey response: Evidence from a field experiment. Journal of Behavioral and Experimental Economics, 107, 102103. https://doi.org/10.1016/j.socec.2023.102103

Cook, B., Costa Leite, J., Rayner, M., Stoffel, S., van Rijn, E., & Wollgast, J. (2023). Consumer Interaction with Sustainability Labelling on Food Products: A Narrative Literature Review. Nutrients, 15(17), 3837. doi.org/10.3390/nu15173837

Gorini, G., Betti, E., Stoffel, S., Falini, P., Iossa, A., Senore, C., Baiocchi, C., Zappa, M., Battisti, F., & Mantellini, P. (2023). Testing behavioral economics messages to increase non-responders' participation in organized colorectal cancer-screening programs: A randomized controlled trial. Preventive Medicine, 107615. https://doi.org/10.1016/j.ypmed.2023.107615

Hirst, Y., Stoffel, S. T., Wang, W., Brewer, H., Timotijevic, L., Raats, M., Flanagan, J. (2023). Understanding Public Attitudes and Willingness to Share Commercial Data for Health Research: A Survey Study in the United Kingdom. JMIR Public Health and Surveillance. 9:e40814 https://doi.org/10.2196/40814

Trottmann M, Blozik E, Hilbig M, LoVerdi D, Pedruzzi M, Scherer T, Weiss M, Pletscher M, Meier N. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data. Swiss Medical Weekly. 2023;153(9):s3441. doi:  https://doi.org/10.57187/s.3441

https://pubmed.ncbi.nlm.nih.gov/37774383/

Bhadhuri A, Dröschel D, Guldimann M, Jetschgo C, Banhazi J, Schwenkglenks M, Sutherland CS. Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland. BMC Health Serv Res. 2022 Jun 28;22(1):837. doi: 10.1186/s12913-022-08211-y. PMID: 35765055; PMCID: PMC9241179. https://pubmed.ncbi.nlm.nih.gov/35765055/

Galactionova K, Salari P, Mattli R, Rachamin Y, Meier R, Schwenkglenks M. Cost-effectiveness, burden of disease and budget impact of inclisiran: dynamic cohort modelling of a real-world population with cardiovascular disease. Pharmacoeconomics 2022;40:791-806.
https://pubmed.ncbi.nlm.nih.gov/35723806/

Gryaznov D, von Niederhäusern B, Speich B, Kasenda B, Ojeda-Ruiz E, Blümle A, Schandelmaier S, Mertz D, Odutayo A, Tomonaga Y, Amstutz A, Pauli-Magnus C, Gloy V, Lohner S, Bischoff K, Wollmann K, Rehner L, Meerpohl JJ, Nordmann A, Klatte K, Ghosh N, Taji Heravi A, Wong J, Chow N, Hong P, McCord-De Iaco KA, Sricharoenchai S, Busse JW, Agarwal A, Saccilotto R, Schwenkglenks M, Moffa G, Hemkens L, Hopewell S, Von Elm E, Briel M. Reporting quality of clinical trial protocols: a repeated cross-sectional study about the Adherence to SPIrit Recommendations in Switzerland, CAnada and GErmany (ASPIRE-SCAGE). BMJ Open 2022;12:e053417.
https://pubmed.ncbi.nlm.nih.gov/35613804/

Menges D, Yebyo HG, Sivec-Muniz S, Haile SR, Barbier MC, Tomonaga Y, Schwenkglenks M, Puhan MA. Treatments for metastatic hormone-sensitive prostate cancer: systematic review, network meta-analysis and benefit-harm assessment. European Urology Oncology 2022;in press.
https://pubmed.ncbi.nlm.nih.gov/35599144/

Aebi NJ, Fink G, Wyss K, Schwenkglenks M, Baenteli I, Caviezel S, Studer A, Trost S, Tschudin S, Schaefert R, Meinlschmidt G; SomPsyNet Consortium. Association of Different Restriction Levels With COVID-19-Related Distress and Mental Health in Somatic Inpatients: A Secondary Analysis of Swiss General Hospital Data. Front Psychiatry 2022;13:872116.
https://pubmed.ncbi.nlm.nih.gov/35592378/

Gruebner O, Wei W, Ulyte A, von Wyl V, Dressel H, Brüngger B, Bähler C, Blozik E, Schwenkglenks M. Small Area Variation of Adherence to Clinical Recommendations: An Example from Switzerland. Health Serv Res Manag Epidemiol 2022;9:23333928221097741.
https://pubmed.ncbi.nlm.nih.gov/35573484/

Speich B, Gryaznov D, Busse JW, Gloy VL, Lohner S, Klatte K, Taji Heravi A, Ghosh N, Lee H, Mansouri A, Marian IR, Saccilotto R, Nury E, Kasenda B, Ojeda-Ruiz E, Schandelmaier S, Tomonaga Y, Amstutz A, Pauli-Magnus C, Bischoff K, Wollmann K, Rehner L, Meerpohl JJ, Nordmann A, Wong J, Chow N, Hong PJ, Mc Cord-De Iaco K, Sricharoenchai S, Agarwal A, Schwenkglenks M, Hemkens LG, von Elm E, Copsey B, Griessbach AN, Schönenberger C, Mertz D, Blümle A, von Niederhäusern B, Hopewell S, Odutayo A, Briel M. Nonregistration, discontinuation, and nonpublication of randomized trials: A repeated metaresearch analysis. PLoS Med 2022;19:e1003980.
https://pubmed.ncbi.nlm.nih.gov/35476675/

Salari P, O'Mahony C, Henrard S, Welsing P, Bhadhuri A, Schur N, Roumet M, Beglinger S, Beck T, Jungo KT, Byrne S, Hossmann S, Knol W, O'Mahony D, Spinewine A, Rodondi N, Schwenkglenks M. Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study. PLoS One 2022;17:e0265507.
https://pubmed.ncbi.nlm.nih.gov/35404990/

Girod M, Coslovsky M, Aeschbacher S, Sticherling C, Reichlin T, Roten L, Rodondi N, Ammann P, Auricchio A, Moschovitis G, Kobza R, Badertscher P, Knecht S, Krisai P, Marugg A, Aebersold H, Hennings E, Serra-Burriel M, Schwenkglenks M, Zuern CS, Bonati LH, Conen D, Osswald S, Kühne M. Association of pulmonary vein isolation and major cardiovascular events in patients with atrial fibrillation. Clin Res Cardiol. 2022.
https://pubmed.ncbi.nlm.nih.gov/35403852/

Cavalli L, Angehrn L, Schindler C, Orsini N, Grob C, Kaufmann M, Steiner LA, Schwenkglenks M, Dell-Kuster S. Number of comorbidities and their impact on perioperative outcome and costs - a single centre cohort study. Swiss Med Wkly 2022;152:w30135.
https://pubmed.ncbi.nlm.nih.gov/35380180/

Kühne M, Krisai P, Coslovsky M, Rodondi N, Müller A, Beer JH, Ammann P, Auricchio A, Moschovitis G, Hayoz D, Kobza R, Shah D, Stephan FP, Schläpfer J, Di Valentino M, Aeschbacher S, Ehret G, Eken C, Monsch A, Roten L, Schwenkglenks M, Springer A, Sticherling C, Reichlin T, Zuern CS, Meyre PB, Blum S, Sinnecker T, Würfel J, Bonati LH, Conen D, Osswald S; Swiss-AF Investigators. Silent brain infarcts impact on cognitive function in atrial fibrillation. Eur Heart J 2022:ehac020. doi: 10.1093/eurheartj/ehac020. Online ahead of print. https://pubmed.ncbi.nlm.nih.gov/35171989/

Early mobilisation and rehabilitation in Swiss intensive care units: a cross-sectional survey. Tomonaga Y, Menges D, Yebyo HG, Fumeaux T, Heise A, Wesch C, Schwenkglenks M*, Puhan MA*. Swiss Med Wkly. 2022 Jan 28;152:w30125. doi: 10.4414/smw.2022.w30125. eCollection 2022 Jan 17. PMID: 35096632 Free article. https://pubmed.ncbi.nlm.nih.gov/35096632/
* Shared last authorship.

Scope A, Bhadhuri A, Pennington B. Systematic Review of Cost-Utility Analyses That Have Included Carer and Family Member Health-Related Quality of Life. Value Health. 2022 Mar 23:S1098-3015(22)00110-3. doi: 10.1016/j.jval.2022.02.008. Epub ahead of print. PMID: 35339379. https://pubmed.ncbi.nlm.nih.gov/35339379/

Morozoff C, Avokpaho E, Puthupalayam Kaliappan S, Simwanza J, Gideon SP, Lungu W, Houngbegnon P, Galactionova K, Sahu M, Kalua K, Luty AJF, Ibikounlé M, Bailey R, Pullan R, Ajjampur SSR, Walson J, Means AR. Costs of community-wide mass drug administration and school-based deworming for soil-transmitted helminths: evidence from a randomised controlled trial in Benin, India and Malawi. BMJ Open. 2022 Jul 8;12(7):e059565. doi: 10.1136/bmjopen-2021-059565. PMID: 35803632; PMCID: PMC9272108. https://pubmed.ncbi.nlm.nih.gov/35803632/ 

Akweongo P, Voetagbe E, Tediosi F, Gadeka DD, Salari P, Aikins M. Community perceptions of enrolment of indigents into the National Health Insurance Scheme in Ghana: a case study of the Livelihood Empowerment against Poverty Programme. Glob Health Res Policy. 2022 Jan 28;7(1):4. doi: 10.1186/s41256-022-00238-2. PMID: 35090567; PMCID: PMC8796334. https://pubmed.ncbi.nlm.nih.gov/35090567/  

Lucas ADP, de Oliveira Ferreira M, Lucas TDP, Salari P. The intergenerational relationship between conditional cash transfers and newborn health. BMC Public Health. 2022 Jan 30;22(1):201. doi: 10.1186/s12889-022-12565-7. PMID: 35094683; PMCID: PMC8801108. https://pubmed.ncbi.nlm.nih.gov/35094683/ 

Ballouz, Tala; Yebyo, Henock; Raineri, Alessia; Puhan, Milo; Bhadhuri, Arjun; Tomonaga, Yuki; Schwenkglenks, Matthias; Antidepressants and cognitive behavioural therapy interventions for major depressive disorder. 2022.
https://www.swissmedicalboard.ch/fileadmin/public/news/2022/SMB_Assessment_Rep_Antidepressiva_2022.pdf

Zgraggen A, Stoffel ST, Barbier MC, Marbet UA. Colorectal cancer surveillance by colonoscopy in a prospective, population-based long-term Swiss screening study - outcomes, adherence, and costs. Z Gastroenterol. 2022 May;60(5):761-778. doi: 10.1055/a-1796-2471. Epub 2022 May 11. PMID: 35545112; PMCID: PMC9179214. https://pubmed.ncbi.nlm.nih.gov/35545112/ 

Stoffel ST, Hvalica Coldwell A, von Wagner C, Herrmann B. Testing temporal frames of colorectal cancer risks: evidence from randomized online experiments. Psychol Health Med. 2022 May 29:1-15. doi: 10.1080/13548506.2022.2061716. Epub ahead of print. PMID: 35635266. https://pubmed.ncbi.nlm.nih.gov/35635266/ 

Mark M, von Moos R, Cathomas R, Stoffel S, Gillessen S. RE: Real-World Use of Bone Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer. J Natl Cancer Inst. 2022 Apr 11;114(4):635-636. doi: 10.1093/jnci/djab216. PMID: 34850058; PMCID: PMC9002272. https://pubmed.ncbi.nlm.nih.gov/34850058/ 

Taylor LC, Kerrison RS, Herrmann B, Stoffel ST. Effectiveness of behavioural economics-based interventions to improve colorectal cancer screening participation: A rapid systematic review of randomised controlled trials. Prev Med Rep. 2022 Mar 3;26:101747. doi: 10.1016/j.pmedr.2022.101747. PMID: 35284211; PMCID: PMC8914541. https://pubmed.ncbi.nlm.nih.gov/35284211/ 

Stoffel ST, McGregor L, Hirst Y, Hanif S, Morris L, von Wagner C. Evaluation of the Call for a Kit intervention to increase bowel cancer screening uptake in Lancashire, England. J Med Screen. 2022 Apr 12:9691413221089184. doi: 10.1177/09691413221089184. Epub ahead of print. PMID: 35410541. https://pubmed.ncbi.nlm.nih.gov/35410541/ 

Stoffel ST, Bombagi M, Kerrison RS, von Wagner C, Herrmann B. Testing Enhanced Active Choice to Optimize Acceptance and Participation in a Population-Based Colorectal Cancer Screening Program in Malta. Behav Med. 2022 Jul-Sep;48(3):141-146. doi: 10.1080/08964289.2020.1828254. Epub 2021 Mar 12. PMID: 33710942. https://pubmed.ncbi.nlm.nih.gov/33710942/

Sendi P, Schwenkglenks M. Risk-Adjusted Performance Measures: A Comment on Elbasha. Pharmacoeconomics 2022;40:739-740. doi: 10.1007/s40273-022-01153-7. https://pubmed.ncbi.nlm.nih.gov/35713875/

Durizzo K, Harttgen K, Tediosi F, Sahu M, Kuwawenaruwa A, Salari P, Günther I. Toward mandatory health insurance in low-income countries? An analysis of claims data in Tanzania. Health Econ. 2022 Aug 7. doi: 10.1002/hec.4568. Epub ahead of print. PMID: 35933731. https://pubmed.ncbi.nlm.nih.gov/35933731/

Stoffel ST, Law JH, Kerrison R, Brewer HR, Flanagan JM, Hirst Y. Testing the Effectiveness of an Animated Decision Aid to Improve Recruitment of Control Participants in a Case-Control Study: Web-Based Experiment. J Med Internet Res. 2022 Aug 26;24(8):e40015. doi: 10.2196/40015. PMID: 36018628; PMCID: PMC9463615. https://pubmed.ncbi.nlm.nih.gov/36018628/

Galactionova K, Loibl S, Salari P, Marmé F, Martin M, Untch M, Bonnefoi HR, Kim SB, Bear HD, McCarthy N, Gelmon KA, García-Sáenz JA, Kelly CM, Reimer T, Toi M, Rugo HS, Gnant M, Makris A, Burchardi N, Schwenkglenks M. Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial. Front Oncol. 2022 Sep 5;12:886831. doi: 10.3389/fonc.2022.886831. PMID: 36132153; PMCID: PMC9484462. https://pubmed.ncbi.nlm.nih.gov/36132153/

Stoffel ST, Colaninno A, Bräm R, Schwenkglenks M. Pneumococcal vaccination among adult risk patient with axial spondyloarthritis in Switzerland: Data from the survey of the ankylosing spondylitis association of Switzerland (SVMB). Vaccine. 2022 Oct 12;40(43):6206-6210. doi: 10.1016/j.vaccine.2022.09.056. Epub 2022 Sep 26. PMID: 36175212. https://pubmed.ncbi.nlm.nih.gov/36175212/

Stoffel ST, Kaushal A, Grimani A, von Wagner C, Sniehotta FF, Vlaev I. Effect of communicating community immunity on COVID-19 vaccine-hesitant people from ethnically diverse backgrounds: an experimental vignette study in the UK. BMJ Open. 2022 Nov 3;12(11):e065804. doi: 10.1136/bmjopen-2022-065804. PMID: 36328392; PMCID: PMC9638751. https://pubmed.ncbi.nlm.nih.gov/36328392/

Meyre PB, Blum S, Hennings E, Aeschbacher S, Reichlin T, Rodondi N, Beer JH, Stauber A, Müller A, Sinnecker T, Moutzouri E, Paladini RE, Moschovitis G, Conte G, Auricchio A, Ramadani A, Schwenkglenks M, Bonati LH, Kühne M, Osswald S, Conen D. Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing. Eur Heart J. 2022 Oct 26:ehac587. doi: 10.1093/eurheartj/ehac587. Epub ahead of print. PMID: 36285887. https://pubmed.ncbi.nlm.nih.gov/36285887/

Barbier MC, Tomonaga Y, Menges D, Yebyo HG, Haile SR, Puhan MA, Schwenkglenks M. Survival modelling and cost-effectiveness analysis of treatments for newly diagnosed metastatic hormone-sensitive prostate cancer. PLoS One. 2022 Nov 3;17(11):e0277282. doi: 10.1371/journal.pone.0277282. PMID: 36327294; PMCID: PMC9632884. https://pubmed.ncbi.nlm.nih.gov/36327294/

Aebersold H, Serra-Burriel M, Foster-Wittassek F, Moschovitis G, Aeschbacher S, Auricchio A, Beer JH, Blozik E, Bonati LH, Conen D, Felder S, Huber CA, Kuehne M, Mueller A, Oberle J, Paladini RE, Reichlin T, Rodondi N, Springer A, Stauber A, Sticherling C, Szucs TD, Osswald S, Schwenkglenks M. Patient clusters and cost trajectories in the Swiss Atrial Fibrillation cohort. Heart. 2022 Nov 4:heartjnl-2022-321520. doi: 10.1136/heartjnl-2022-321520. Epub ahead of print. PMID: 36332981. https://pubmed.ncbi.nlm.nih.gov/36332981/

Dr. Soheila Aghlmandi PhD; Dr. Arjun Bhadhuri, PhD; Prof. Heiner C. Bucher, MD, MPH; Koen de Nijs, MSc; Dr. Hannah Ewald PhD; Dr. sc. Dominik Glinz, PhD, MSc; Dr. Viktoria Gloy, PhD; Alexandra Griessbach, MSc; Dr. David Shaw, PhD, MA, MSc, MML; Ala Taji Heravi, MSc; Dr. Kevin ten Haaf, PhD, MSc; Dr. Yuki Tomonaga, PhD, MSc.  Low-dose CT screening for lung cancer. 2022. https://cancerscreeningcommittee.ch/themen/lungenkrebs-screening-mittels-ldct/   

Twerenbold S, Schur N, Wittwer N, Schneider C, Marxer C, Spondlin J, Schwenkglenks M, Meier C. Helsana-Arzneimittelreport für die Schweiz 2022. https://reports.helsana.ch/en/drugs2022/

Marbet, U.A., Stoffel, S.T. & Brunner-Schaub, N. Dickdarmkrebsscreening in der Schweiz: Sind unsere Patienten genügend motiviert?. Schweiz. Gastroenterol. 3, 110–120 (2022). https://doi.org/10.1007/s43472-022-00076-0

Siqeca F, Yip O, Mendieta MJ, Schwenkglenks M, Zeller A, De Geest S, Zúñiga F, Stenz S, Briel M, Quinto C, Blozik E, Deschodt M, Obas K, Dhaini S. Factors associated with health-related quality of life among home-dwelling older adults aged 75 or older in Switzerland: a cross-sectional study. Health Qual Life Outcomes. 2022 Dec 21;20(1):166. doi: 10.1186/s12955-022-02080-z. PMID: 36544173. https://pubmed.ncbi.nlm.nih.gov/36544173/

Yip O, Mendieta MJ, Zullig LL, Zeller A, De Geest S, Deschodt M, Siqeca F, Zúñiga F, Briel M, Schwenkglenks M, Quinto C, Dhaini S. Protocol for a mixed methods feasibility and implementation study of a community-based integrated care model for home-dwelling older adults: The INSPIRE project. PLoS One. 2022 Dec 21;17(12):e0278767. doi: 10.1371/journal.pone.0278767. PMID: 36542596. https://pubmed.ncbi.nlm.nih.gov/36542596/

Lambiris MJ, Venga GN, Ssempala R, Balogun V, Galactionova K, Musiitwa M, et al. Health system readiness and the implementation of rectal artesunate for severe malaria in sub-Saharan Africa: an analysis of real-world costs and constraints. The Lancet Global Health. https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(22)00507-1/fulltext

Twerenbold S, Schur N, Zappalà T, Gut S, Stoffel S, Salari P, Galactionova K, Schwenkglenks M, Meier C. Helsana-Arzneimittelreport für die Schweiz 2021. https://reports.helsana.ch/en/drugs2021/

Galactionova K, Smith TA, Penny MA. Insights from modelling malaria vaccines for policy decisions: the focus on RTS,S. Malar J. 2021 Nov 18;20(1):439. doi: 10.1186/s12936-021-03973-y. PMID: 34794430; PMCID: PMC8600337.

Galactionova K, Sahu M, Gideon SP, Puthupalayam Kaliappan S, Morozoff C, Ajjampur SSR, Walson J, Rubin Means A, Tediosi F. Costing interventions in the field: preliminary cost estimates and lessons learned from an evaluation of community-wide mass drug administration for elimination of soil-transmitted helminths in the DeWorm3 trial. BMJ Open. 2021 Jul 5;11(7):e049734. doi: 10.1136/bmjopen-2021-049734. PMID: 34226233; PMCID: PMC8258667.

Lupatsch JE, Kreis C, Konstantinoudis G, Ansari M, Kuehni CE, Spycher BD. Birth characteristics and childhood leukemia in Switzerland: a register-based case-control study. Cancer Causes Control. 2021 Jul;32(7):713-723. doi: 10.1007/s10552-021-01423-3. Epub 2021 Apr 20. PMID: 33877514; PMCID: PMC8184536.

Stoffel ST, von Moos R, Thürlimann B, Cathomas R, Gillessen S, Zürrer-Härdi U, von Briel T, Anchisi S, Feller A, Schär C, Dietrich D, Schwenkglenks M, Lupatsch JE, Mark MT. Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland - the SAKK 95/16 prostate study. Swiss Med Wkly. 2021 Mar 1;151:w20464. doi: 10.4414/smw.2021.20464. PMID: 33705559.

Akweongo P, Aikins M, Wyss K, Salari P, Tediosi F. Insured clients out-of-pocket payments for health care under the national health insurance scheme in Ghana. BMC Health Serv Res. 2021 May 8;21(1):440. doi: 10.1186/s12913-021-06401-8. PMID: 33964911; PMCID: PMC8106211.

Akweongo P, Chatio ST, Owusu R, Salari P, Tediosi F, Aikins M. Correction: How does it affect service delivery under the National Health Insurance Scheme in Ghana? Health providers and insurance managers perspective on submission and reimbursement of claims. PLoS One. 2021 Jun 10;16(6):e0253357. doi: 10.1371/journal.pone.0253357. Erratum for: PLoS One. 2021 Mar 2;16(3):e0247397. PMID: 34111214; PMCID: PMC8191894.

Aikins M, Tabong PT, Salari P, Tediosi F, Asenso-Boadi FM, Akweongo P. Positioning the National Health Insurance for financial sustainability and Universal Health Coverage in Ghana: A qualitative study among key stakeholders. PLoS One. 2021 Jun 15;16(6):e0253109. doi: 10.1371/journal.pone.0253109. PMID: 34129630; PMCID: PMC8205146.

Stoffel ST, Hirst Y, Ghanouni A, Waller J, von Wagner C. Offering disinclined people the choice between different screening appointments: a randomised online survey. Psychol Health. 2021 Sep;36(9):1135-1146. doi: 10.1080/08870446.2020.1834559. Epub 2020 Oct 18. PMID: 33073598.

Mark M, von Moos R, Cathomas R, Stoffel S, Gillessen S. RE: Real-World Use of Bone Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer. J Natl Cancer Inst. 2021 Nov 29:djab216. doi: 10.1093/jnci/djab216. Epub ahead of print. PMID: 34850058.

Stoffel S, Kioupi S, Ioannou D, Kerrison RS, von Wagner C, Herrmann B. Testing messages from behavioral economics to improve participation in a population-based colorectal cancer screening program in Cyprus: Results from two randomized controlled trials. Prev Med Rep. 2021 Jul 28;24:101499. doi: 10.1016/j.pmedr.2021.101499. PMID: 34430189; PMCID: PMC8371188.

Allan JL, Andelic N, Bender KA, Powell D, Stoffel S, Theodossiou I. Employment contracts and stress: Experimental evidence. Journal of Economic Behavior & Organization. 2021 Jul 1;187:360-73.

Stoffel S, Herrmann B. How Does Communicating Herd Immunity Affect Immunization Intentions?: Evidence From a Cross-Country Online Experiment. International Journal of Applied Behavioral Economics (IJABE). 2021 Oct 1;10(4):12-20.

Packer J, Russell SJ, Ridout D, Hope S, Conolly A, Jessop C, Robinson OJ, Stoffel ST, Viner RM, Croker H. Assessing the Effectiveness of Front of Pack Labels: Findings from an Online Randomised-Controlled Experiment in a Representative British Sample. Nutrients. 2021 Mar 10;13(3):900. doi: 10.3390/nu13030900. PMID: 33802115; PMCID: PMC7999818.

Stoffel ST, Bombagi M, Kerrison RS, von Wagner C, Herrmann B. Testing Enhanced Active Choice to Optimize Acceptance and Participation in a Population-Based Colorectal Cancer Screening Program in Malta. Behav Med. 2021 Mar 12:1-6. doi: 10.1080/08964289.2020.1828254. Epub ahead of print. PMID: 33710942.

Barbier MC, Pardo E, Panje CM, Gautschi O, Lupatsch JE; Swiss Group for Clinical Cancer Research (SAKK). A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 expression in Switzerland. Eur J Health Econ. 2021 Jul;22(5):669-677. doi: 10.1007/s10198-021-01282-4. Epub 2021 Mar 21. PMID: 33745093; PMCID: PMC8214587.

Menges D, Seiler B, Tomonaga Y, Schwenkglenks M, Puhan MA, Yebyo HG. Systematic early versus late mobilization or standard early mobilization in mechanically ventilated adult ICU patients: systematic review and meta-analysis. Crit Care. 2021 Jan 6;25(1):16. doi: 10.1186/s13054-020-03446-9. PMID: 33407707; PMCID: PMC7789482.

Meyre PB, Springer A, Aeschbacher S, Blum S, Rodondi N, Beer JH, Di Valentino M, Ammann P, Blum M, Mathys R, Meyer-Zürn C, Bonati LH, Sticherling C, Schwenkglenks M, Kühne M, Conen D, Osswald S; Swiss-AF investigators. Association of psychosocial factors with all-cause hospitalizations in patients with atrial fibrillation. Clin Cardiol. 2021 Jan;44(1):51-57. doi: 10.1002/clc.23503. Epub 2020 Nov 10. PMID: 33169859; PMCID: PMC7803348.

Siqeca F, Obas K, Yip O, Stenz S, Vounatsou P, Briel M, Schwenkglenks M, Quinto C, Blozik E, Zeller A, Zullig LL, De Geest S, Deschodt M. The INSPIRE Population Survey: development, dissemination and respondent characteristics. BMC Med Res Methodol. 2021 Jun 24;21(1):131. doi: 10.1186/s12874-021-01329-3. PMID: 34162324; PMCID: PMC8223353.

Bähler C, Brüngger B, Ulyte A, Schwenkglenks M, von Wyl V, Dressel H, Gruebner O, Wei W, Blozik E. Temporal trends and regional disparities in cancer screening utilization: an observational Swiss claims-based study. BMC Public Health. 2021 Jan 5;21(1):23. doi: 10.1186/s12889-020-10079-8. PMID: 33402140; PMCID: PMC7786957.

Gubler-Gut BE, Pöhlmann J, Flatz A, Schwenkglenks M, Rohrmann S. Cost-effectiveness of physical activity interventions in cancer survivors of developed countries: a systematic review. J Cancer Surviv. 2021 Dec;15(6):961-975. doi: 10.1007/s11764-021-01002-0. Epub 2021 Feb 23. PMID: 33624172; PMCID: PMC8521580.

Sendi P, Matter-Walstra K, Schwenkglenks M. Handling Uncertainty in Cost-Effectiveness Analysis: Budget Impact and Risk Aversion. Healthcare (Basel). 2021 Oct 22;9(11):1419. doi: 10.3390/healthcare9111419. PMID: 34828466; PMCID: PMC8622052.

Reinau D, Schur N, Twerenbold S, Blozik E, Früh M, Signorell A, Schwenkglenks M, Meier CR. Utilisation patterns and costs of lipid-lowering drugs in Switzerland 2013-2019. Swiss Med Wkly. 2021 Sep 1;151:w30018. doi: 10.4414/SMW.2021.w30018. PMID: 34495601.

Brüngger B, Bähler C, Schwenkglenks M, Ulyte A, Dressel H, von Wyl V, Gruebner O, Wei W, Serra-Burriel M, Blozik E. Surgical procedures in inpatient versus outpatient settings and its potential impact on follow-up costs. Health Policy. 2021 Oct;125(10):1351-1358. doi: 10.1016/j.healthpol.2021.07.006. Epub 2021 Jul 21. PMID: 34348846.

Schur N, Gudala K, Vudumula U, Vadapalle S, Bhadhuri A, Casanova A, Adlard N, Schwenkglenks M. Cost Effectiveness and Budget Impact of Siponimod Compared to Interferon Beta-1a in the Treatment of Adult Patients with Secondary Progressive Multiple Sclerosis with Active Disease in Switzerland. Pharmacoeconomics. 2021 May;39(5):563-577. doi: 10.1007/s40273-021-01023-8. Epub 2021 Apr 1. PMID: 33791945; PMCID: PMC8079303.

Aebi NJ, Caviezel S, Schaefert R, Meinlschmidt G, Schwenkglenks M, Fink G, Riedo L, Leyhe T, Wyss K; SomPsyNet Consortium. A qualitative study to investigate Swiss hospital personnel's perceived importance of and experiences with patient's mental-somatic multimorbidities. BMC Psychiatry. 2021 Jul 12;21(1):349. doi: 10.1186/s12888-021-03353-5. PMID: 34253168; PMCID: PMC8274261.

Adam L, Feller M, Syrogiannouli L, Del-Giovane C, Donzé J, Baumgartner C, Segna D, Floriani C, Roten L, Fischer U, Aeschbacher S, Moschovitis G, Schläpfer J, Shah D, Amman P, Kobza R, Schwenkglenks M, Kühne M, Bonati LH, Beer J, Osswald S, Conen D, Aujesky D, Rodondi N; SWISS-AF Investigators. Novel bleeding risk score for patients with atrial fibrillation on oral anticoagulants, including direct oral anticoagulants. J Thromb Haemost. 2021 Apr;19(4):931-940. doi: 10.1111/jth.15251. Epub 2021 Feb 24. PMID: 33501722.

Ulyte A, Wei W, Gruebner O, Bähler C, Brüngger B, Blozik E, von Wyl V, Schwenkglenks M, Dressel H. Are weak or negative clinical recommendations associated with higher geographical variation in utilisation than strong or positive recommendations? Cross-sectional study of 24 healthcare services. BMJ Open. 2021 May 10;11(5):e044090. doi: 10.1136/bmjopen-2020-044090. PMID: 33972336; PMCID: PMC8112440.

Papazoglou DD, Baretella O, Feller M, Del Giovane C, Moutzouri E, Aujesky D, Schwenkglenks M, O'Mahony D, Knol W, Dalleur O, Rodondi N, Baumgartner C. Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients. PLoS One. 2021 Nov 16;16(11):e0260112. doi: 10.1371/journal.pone.0260112. PMID: 34784405; PMCID: PMC8594840.

Bommer C, Lupatsch J, Bürki N, Schwenkglenks M. Cost-utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland. Eur J Health Econ. 2021 Nov 12. doi: 10.1007/s10198-021-01396-9. Epub ahead of print. PMID: 34767113.

Jungo KT, Meier R, Valeri F, Schwab N, Schneider C, Reeve E, Spruit M, Schwenkglenks M, Rodondi N, Streit S. Baseline characteristics and comparability of older multimorbid patients with polypharmacy and general practitioners participating in a randomized controlled primary care trial. BMC Fam Pract. 2021 Jun 22;22(1):123. doi: 10.1186/s12875-021-01488-8. PMID: 34157981; PMCID: PMC8220761.

Kappos EA, Schulz A, Regan MM, Moffa G, Harder Y, Ribi K, Potter S, Pusic AL, Fehr MK, Hemkens LG, Holzbach T, Farhadi J, Simonson C, Knauer M, Verstappen R, Bucher HC, Zwahlen D, Zimmermann F, Schwenkglenks M, Mucklow R, Shaw J, Bjelic-Radisic V, Chiorescu A, Chun YS, Farah S, Xiaosong C, Nigard L, Kuemmel S, Reitsamer R, Hauschild M, Fulco I, Tausch C, Fischer T, Sarlos D, Constantinescu MA, Lupatsch JE, Fitzal F, Heil J, Matrai Z, de Boniface J, Kurzeder C, Haug M, Weber WP. Prepectoral versus subpectoral implant-based breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy (OPBC-02/ PREPEC): a pragmatic, multicentre, randomised, superiority trial. BMJ Open. 2021 Sep 2;11(9):e045239. doi: 10.1136/bmjopen-2020-045239. PMID: 34475143; PMCID: PMC8413865.

Barbier M, Durno N, Bennison C, Örtli M, Knapp C, Schwenkglenks M. Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland. Eur J Health Econ. 2021 Nov 10. doi: 10.1007/s10198-021-01398-7. Epub ahead of print. PMID: 34757508.

Menges D, Yebyo H, Sivec-Muniz S, Haile S, Puhan M, Barbier M, Tomonaga Y, Schwenkglenks M. Clinical Effectiveness, Safety and Cost-Effectiveness of Chemotherapy or Radiotherapy plus Androgen Deprivation Therapy (ADT) versus ADT Alone in Newly Diagnosed Metastatic Hormone-Sensitive Prostate Cancer (2021). Swiss Medical Board https://www.swissmedicalboard.ch/fileadmin/public/news/2021/SMB_Assessment_Rep_Prostate_Cancer_Drugs_2021.pdf

Lohner S, Gryaznov D, von Niederhäusern B, Speich B, Kasenda B, Ojeda-Ruiz E, Schandelmaier S, Mertz D, Odutayo A, Tomonaga Y, Amstutz A, Pauli-Magnus C, Gloy V, Bischoff K, Wollmann K, Rehner L, Meerpohl JJ, Nordmann A, Klatte K, Ghosh N, Heravi AT, Wong J, Chow N, Hong PJ, McCord K, Sricharoenchai S, Busse JW, Agarwal A, Saccilotto R, Schwenkglenks M, Moffa G, Hemkens LG, Hopewell S, von Elm E, Blümle A, Briel M. Reporting quality of trial protocols improved for non-regulated interventions but not regulated interventions: A repeated cross-sectional study. J Clin Epidemiol. 2021 Nov;139:340-349. doi: 10.1016/j.jclinepi.2021.05.011. Epub 2021 May 23. PMID: 34029678.

Blum MR, Sallevelt BTGM, Spinewine A, O'Mahony D, Moutzouri E, Feller M, Baumgartner C, Roumet M, Jungo KT, Schwab N, Bretagne L, Beglinger S, Aubert CE, Wilting I, Thevelin S, Murphy K, Huibers CJA, Drenth-van Maanen AC, Boland B, Crowley E, Eichenberger A, Meulendijk M, Jennings E, Adam L, Roos MJ, Gleeson L, Shen Z, Marien S, Meinders AJ, Baretella O, Netzer S, de Montmollin M, Fournier A, Mouzon A, O'Mahony C, Aujesky D, Mavridis D, Byrne S, Jansen PAF, Schwenkglenks M, Spruit M, Dalleur O, Knol W, Trelle S, Rodondi N. Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial. BMJ. 2021 Jul 13;374:n1585. doi: 10.1136/bmj.n1585. PMID: 34257088; PMCID: PMC8276068.

Tomonaga Y, Zens KD, Lang P, Born R, Schwenkglenks M; Swiss Sentinel Surveillance Network. Productivity losses due to influenza and influenza-like illness in Switzerland: results of the Swiss Sentinel Surveillance Network in a non-pandemic era. Swiss Med Wkly. 2021 Aug 23;151(33-34). doi: 10.4414/SMW.2021.w30022. PMID: 34495605.

Byber K, Radtke T, Norbäck D, Hitzke C, Imo D, Schwenkglenks M, Puhan MA, Dressel H, Mutsch M. Humidification of indoor air for preventing or reducing dryness symptoms or upper respiratory infections in educational settings and at the workplace. Cochrane Database Syst Rev. 2021 Dec 10;12(12):CD012219. doi: 10.1002/14651858.CD012219.pub2. PMID: 34891215; PMCID: PMC8664457.

Romanens M, Adams A, Sudano I, Bojara W, Balint S, Warmuth W, Szucs TD. Prediction of cardiovascular events with traditional risk equations and total plaque area of carotid atherosclerosis: The Arteris Cardiovascular Outcome (ARCO) cohort study. Prev Med. 2021 Jun;147:106525. doi: 10.1016/j.ypmed.2021.106525. Epub 2021 Mar 18. PMID: 33745952.

Jeiziner C, Suter K, Wernli U, Barbarino JM, Gong L, Whirl-Carrillo M, Klein TE, Szucs TD, Hersberger KE, Meyer Zu Schwabedissen HE. Pharmacogenetic information in Swiss drug labels - a systematic analysis. Pharmacogenomics J. 2021 Aug;21(4):423-434. doi: 10.1038/s41397-020-00195-4. Epub 2020 Oct 17. PMID: 33070160; PMCID: PMC8292148.

Horgan D, Metspalu A, Ouillade MC, Athanasiou D, Pasi J, Adjali O, Harrison P, Hermans C, Codacci-Pisanelli G, Koeva J, Szucs T, Cursaru V, Belina I, Bernini C, Zhuang S, McMahon S, Toncheva D, Thum T. Propelling Healthcare with Advanced Therapy Medicinal Products: A Policy Discussion. Biomed Hub. 2020 Dec 3;5(3):130-152

Drack S, Szucs TD. COVID-19-Impfpflicht: Möglichkeiten und Haftung Von Privatrechtlichen Arbeitgebern Von Gesundheitspersonal. Jusletter; 24.6.2021

Szucs, Thomas D. (Book). Rechtliche Aspekte von Arzneimitteln mit genomischen Biomarkern im Label. Eine Beurteilung aus Sicht des schweizerischen Rechts. Editions Weblaw 2020

Szucs, Thomas D. (Book chapter). Die Präzisionsmedizin – massgeschneiderte Medizin statt Massenware. In: Hansjakob Müller / Hans-Beat Hadorn (Hg.) Humangenetik und Anthropologie heute. Schwabe Verlag 2022

Bhadhuri A, Sutherland CS, Suter-Zimmermann K, Schwenkglenks M, Rohrmann S, Hysaj O, Tomonaga Y, Pestoni G, Karavasiloglou N. Vitamin D testing. Swiss Federal Office of Public Health
https://www.bag.admin.ch/bag/en/home/versicherungen/krankenversicherung/krankenversicherung-leistungen-tarife/hta/hta-projekte/vitamindtests.html

Schur N, Twerenbold S, Reinau D, Schwenkglenks M, Meier C. Helsana-Arzneimittelreport für die Schweiz 2020. https://www.helsana.ch/de/helsana-gruppe/medien-publikationen/mitteilungen/arzneimittelreport-2020.html

von Wyl V, Ulyte A, Wei W, Radovanovic D, Grübner O, Brüngger B, Bähler C, Blozik E, Dressel H, Schwenkglenks M. Going beyond the mean: economic benefits of myocardial infarction secondary prevention. BMC Health Serv Res. 2020 Dec 4;20(1):1125. doi: 10.1186/s12913-020-05985-x. PMID: 33276786; PMCID: PMC7718707.

Salari P, Fürst T, Knopp S, Rollinson D, Kabole F, Khamis MI, Omar MA, Bacon O, Ali SM, Utzinger J, Tediosi F. Financial Costs of the Zanzibar Elimination of Schistosomiasis Transmission Project. Am J Trop Med Hyg. 2020 Dec;103(6):2260-2267. doi: 10.4269/ajtmh.20-0252. Epub 2020 Sep 24. PMID: 32996446; PMCID: PMC7695112.

Wei W, Ulyte A, Gruebner O, von Wyl V, Dressel H, Brüngger B, Blozik E, Bähler C, Braun J, Schwenkglenks M. Degree of regional variation and effects of health insurance-related factors on the utilization of 24 diverse healthcare services - a cross-sectional study. BMC Health Serv Res. 2020 Nov 27;20(1):1091. doi: 10.1186/s12913-020-05930-y. PMID: 33246452; PMCID: PMC7694910.

Latimer NR, Bhadhuri A, Alshreef AO, Palmer R, Cross E, Dimairo M, Julious S, Cooper C, Enderby P, Brady MC, Bowen A, Bradley E, Harrison M. Self-managed, computerised word finding therapy as an add-on to usual care for chronic aphasia post-stroke: An economic evaluation. Clin Rehabil. 2020 Nov 24:269215520975348. doi: 10.1177/0269215520975348. Epub ahead of print. PMID: 33233972.

Meyre PB, Springer A, Aeschbacher S, Blum S, Rodondi N, Beer JH, Di Valentino M, Ammann P, Blum M, Mathys R, Meyer-Zürn C, Bonati LH, Sticherling C, Schwenkglenks M, Kühne M, Conen D, Osswald S; Swiss-AF investigators. Association of psychosocial factors with all-cause hospitalizations in patients with atrial fibrillation. Clin Cardiol. 2020 Nov 10. doi: 10.1002/clc.23503. Epub ahead of print. PMID: 33169859.

Gryaznov D, Odutayo A, von Niederhäusern B, Speich B, Kasenda B, Ojeda-Ruiz E, Blümle A, Schandelmaier S, Mertz D, Tomonaga Y, Amstutz A, Pauli-Magnus C, Gloy V, Bischoff K, Wollmann K, Rehner L, Lohner S, Meerpohl JJ, Nordmann A, Klatte K, Ghosh N, Heravi AT, Wong J, Chow N, Hong PJ, Cord KM, Sricharoenchai S, Busse JW, Agarwal A, Saccilotto R, Schwenkglenks M, Moffa G, Hemkens LG, Hopewell S, von Elm E, Briel M. Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects. Trials. 2020 Oct 28;21(1):896. doi: 10.1186/s13063-020-04808-y. PMID: 33115541; PMCID: PMC7594472.

Stoffel ST, Hirst Y, Ghanouni A, Waller J, von Wagner C. Offering disinclined people the choice between different screening appointments: a randomised online survey. Psychol Health. 2020 Oct 18:1-12. doi: 10.1080/08870446.2020.1834559. Epub ahead of print. PMID: 33073598.

Jeiziner C, Suter K, Wernli U, Barbarino JM, Gong L, Whirl-Carrillo M, Klein TE, Szucs TD, Hersberger KE, Meyer Zu Schwabedissen HE. Pharmacogenetic information in Swiss drug labels - a systematic analysis. Pharmacogenomics J. 2020 Oct 17. doi: 10.1038/s41397-020-00195-4. Epub ahead of print. PMID: 33070160.

Springer A, Monsch AU, Dutilh G, Coslovsky M, Kievit RA, Bonati LH, Conen D, Aeschbacher S, Beer JH, Schwenkglenks M, Fischer U, Meyer-Zuern CS, Conte G, Moutzouri E, Moschovitis G, Kühne M, Osswald S; Swiss-AF Study Investigators. A factor score reflecting cognitive functioning in patients from the Swiss Atrial Fibrillation Cohort Study (Swiss-AF). PLoS One. 2020 Oct 9;15(10):e0240167. doi: 10.1371/journal.pone.0240167. PMID: 33035257; PMCID: PMC7546506.

Bhadhuri A, Kind P, Salari P, Jungo KT, Boland B, Byrne S, Hossmann S, Dalleur O, Knol W, Moutzouri E, O'Mahony D, Murphy KD, Wisselink L, Rodondi N, Schwenkglenks M. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy. Health Qual Life Outcomes. 2020 Sep 29;18(1):317. doi: 10.1186/s12955-020-01564-0. PMID: 32993637; PMCID: PMC7526382.

Galactionova K, Velarde M, Silumbe K, Miller J, McDonnell A, Aguas R, Smith TA, Penny MA. Costing malaria interventions from pilots to elimination programmes. Malar J. 2020 Sep 14;19(1):332. doi: 10.1186/s12936-020-03405-3. PMID: 32928227; PMCID: PMC7491157.

Becker C, Schwenkglenks M, Frueh M, Reich O, Meier CR. Use of selective serotonin reuptake inhibitors, other antidepressant medication, and risk of cataract: a case-control study based on Swiss claims data. Eur J Clin Pharmacol. 2020 Sep;76(9):1329-1335. doi: 10.1007/s00228-020-02923-y. Epub 2020 Jun 6. PMID: 32504184.

Kaushal A, Stoffel ST, Kerrison R, von Wagner C. Preferences for different diagnostic modalities to follow up abnormal colorectal cancer screening results: a hypothetical vignette study. BMJ Open. 2020 Jul 26;10(7):e035264. doi: 10.1136/bmjopen-2019-035264. PMID: 32713846; PMCID: PMC7383951.

Ulyte A, Wei W, Gruebner O, Bähler C, Brüngger B, Blozik E, Dressel H, Schwenkglenks M, von Wyl V. Insights into the protective effects of influenza vaccination: More hospitalizations but lower follow-up mortality during the 2014/15 influenza season in a Swiss cohort. Vaccine. 2020 Jul 14;38(33):5187-5193. doi: 10.1016/j.vaccine.2020.06.019. Epub 2020 Jun 19. PMID: 32571721.

Widén J, Ivarsson M, Schalin L, Vrouchou P, Schwenkglenks M, Heimbürger O, Ademi Z, Sutherland CS. Cost-Effectiveness Analysis of Patiromer in Combination with Renin-Angiotensin-Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden. Pharmacoeconomics. 2020 Jul;38(7):747-764. doi: 10.1007/s40273-020-00902-w. PMID: 32239480.

Campbell CH, Binder S, King CH, Knopp S, Rollinson D, Person B, Webster B, Allan F, Utzinger J, Ame SM, Ali SM, Kabole F, N'Goran EK, Tediosi F, Salari P, Ouattara M, Diakité NR, Hattendorf J, S Andros T, Kittur N, Colley DG. SCORE Operational Research on Moving toward Interruption of Schistosomiasis Transmission. Am J Trop Med Hyg. 2020 Jul;103(1_Suppl):58-65. doi: 10.4269/ajtmh.19-0825. PMID: 32400354; PMCID: PMC7351301.

Stempfel S, Aeschbacher S, Blum S, Meyre P, Gugganig R, Beer JH, Kobza R, Kühne M, Moschovitis G, Menghini G, Novak J, Osswald S, Rodondi N, Moutzouri E, Schwenkglenks M, Witassek F, Conen D, Sticherling C; Swiss-AF study investigators. Symptoms and quality of life in patients with coexistent atrial fibrillation and atrial flutter. Int J Cardiol Heart Vasc. 2020 Jun 16;29:100556. doi: 10.1016/j.ijcha.2020.100556. PMID: 32577496; PMCID: PMC7303549.

Pillai N, Lupatsch JE, Dusheiko M, Schwenkglenks M, Maillard M, Sutherland CS, Pittet VEH; Swiss IBD Cohort Study group. Evaluating the Cost-Effectiveness of Early Compared with Late or No Biologic Treatment to Manage Crohn's Disease using Real-World Data. J Crohns Colitis. 2020 May 21;14(4):490-500. doi: 10.1093/ecco-jcc/jjz169. PMID: 31630164.

von Wagner C, Verstraete W, Hirst Y, Nicholson BD, Stoffel ST, Laszlo H. Public preferences for using quantitative faecal immunochemical test versus colonoscopy as diagnostic test for colorectal cancer: evidence from an online survey. BJGP Open. 2020 May 1;4(1):bjgpopen20X101007. doi: 10.3399/bjgpopen20X101007. PMID: 32019773; PMCID: PMC7330201.

Leo CP, Leo C, Szucs TD. Breast cancer drug approvals by the US FDA from 1949 to 2018. Nat Rev Drug Discov. 2020 Jan;19(1):11. doi: 10.1038/d41573-019-00201-w. Erratum in: Nat Rev Drug Discov. 2020 Apr;19(4):291. PMID: 31907423.

Ulyte A, Wei W, Dressel H, Gruebner O, von Wyl V, Bähler C, Blozik E, Brüngger B, Schwenkglenks M. Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines. PLoS One. 2020 Apr 16;15(4):e0231409. doi: 10.1371/journal.pone.0231409. PMID: 32298325; PMCID: PMC7162274.

Mattli R, Farcher R, Syleouni ME, Wieser S, Probst-Hensch N, Schmidt-Trucksäss A, Schwenkglenks M. Physical Activity Interventions for Primary Prevention in Adults: A Systematic Review of Randomized Controlled Trial-Based Economic Evaluations. Sports Med. 2020 Apr;50(4):731-750. doi: 10.1007/s40279-019-01233-3. PMID: 31755043.

Panje CM, Lupatsch JE, Barbier M, Pardo E, Lorez M, Dedes KJ, Aebersold DM, Plasswilm L, Gautschi O, Schwenkglenks M; Swiss Group for Clinical Cancer Research (SAKK). A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland. Ann Oncol. 2020 Apr;31(4):501-506. doi: 10.1016/j.annonc.2020.01.007. Epub 2020 Jan 16. PMID: 32107097.

Grossmann R, Schneider MA, Linecker M, Lehn JM, Nicolau C, Traber M, Tay F, Vicente D, Jetter A, Mollet A,Szucs T, Graf R, Clavien PA, Limani P. Interprofessional and interdisciplinary collaboration for early phase oncological clinical trials in academia-Myo-inositoltrispyrophophate as model. Pharmacol Res. 2020 Apr;154:104238. doi: 10.1016/j.phrs.2019.04.022. Epub 2019 Apr 19. PMID: 31009662.

Salari P, Fürst T, Knopp S, Utzinger J, Tediosi F. Cost of interventions to control schistosomiasis: A systematic review of the literature. PLoS Negl Trop Dis. 2020 Mar 30;14(3):e0008098. doi: 10.1371/journal.pntd.0008098. PMID: 32226008; PMCID: PMC7145200.

Meyre P, Aeschbacher S, Blum S, Coslovsky M, Beer JH, Moschovitis G, Rodondi N, Baretella O, Kobza R, Sticherling C, Bonati LH, Schwenkglenks M, Kühne M, Osswald S, Conen D; Swiss-AF and BEAT-AF Investigators. The Admit-AF risk score: A clinical risk score for predicting hospital admissions in patients with atrial fibrillation. Eur J Prev Cardiol. 2020 Mar 30:2047487320915350. doi: 10.1177/2047487320915350. Epub ahead of print. PMID: 32228053.

von Wagner C, Cadar D, Hackett RA, Demakakos P, Beeken RJ, Cooper Bailey S, Wolf M, Steptoe A, Renzi C, Stoffel ST. Type 2 diabetes and colorectal cancer screening: Findings from the English Longitudinal Study of Ageing. J Med Screen. 2020 Mar;27(1):25-30. doi: 10.1177/0969141319874834. Epub 2019 Sep 23. PMID: 31547753.

Ghanouni A, Waller J, Stoffel ST, Vlaev I, von Wagner C. Acceptability of risk-stratified breast screening: Effect of the order of presenting risk and benefit information. J Med Screen. 2020 Mar;27(1):52-56. doi: 10.1177/0969141319877669. Epub 2019 Oct 1. PMID: 31575328.

Leo CP, Hentschel B, Szucs TD, Leo C. FDA and EMA Approvals of New Breast Cancer Drugs-A Comparative Regulatory Analysis. Cancers (Basel). 2020 Feb 13;12(2):437. doi: 10.3390/cancers12020437. PMID: 32069837; PMCID: PMC7072445.

Schneider R, Reinau D, Schur N, Blozik E, Früh M, Signorell A, Heininger U, Schwenkglenks M, Meier CR. Coverage rates and timeliness of nationally recommended vaccinations in Swiss preschool children: A descriptive analysis using claims data. Vaccine. 2020 Feb 5;38(6):1551-1558. doi: 10.1016/j.vaccine.2019.11.057. Epub 2019 Nov 30. PMID: 31791812.

Wei W, Gruebner O, von Wyl V, Dressel H, Ulyte A, Brüngger B, Blozik E, Bähler C, Braun J, Schwenkglenks M. Exploring geographic variation of and influencing factors for utilization of four diabetes management measures in Swiss population using claims data. BMJ Open Diabetes Res Care. 2020 Feb;8(1):e001059. doi: 10.1136/bmjdrc-2019-001059. PMID: 32094222; PMCID: PMC7039601.

Frey K, Lociciro S, Blank P, Schwenkglenks M, Dubois-Arber F, Rosenbrock R, Lehner A, Staub R, Derendinger S, Schmidt A, Bize R, Kübler D, Low N. 'Break the Chains 2015' community-based HIV prevention campaign for men who have sex with men in Switzerland: non-randomised evaluation and cost analysis. BMJ Open. 2020 Jan 21;10(1):e032459. doi: 10.1136/bmjopen-2019-032459. PMID: 31969364; PMCID: PMC7044933.

Frey K, Lociciro S, Blank P, SchwenkglenksM, Dubois-Arber F, Rosenbrock R, Lehner A, Staub R, Derendinger S, Schmidt A, Bize R, Kübler D, Low N. 'Break the Chains 2015' community-based HIV prevention campaign for men who have sex with men in Switzerland: non-randomised evaluation and cost analysis. BMJ Open January 3, 2020;10:e032459. doi: 10.1136/bmjopen-2019-032459. https://bmjopen.bmj.com/content/10/1/e032459

Speich B, Gloy V, Schur N, Ewald H, Hemkens LG, Schwenkglenks M, Briel M; MAking Randomized Trials Affordable (MARTA) Group. A scoping review shows that several nonvalidated budget planning tools for randomized trials are available. J Clin Epidemiol. 2020 Jan;117:9-19. doi: 10.1016/j.jclinepi.2019.09.009. Epub 2019 Sep 15. PMID: 31533072.

Menges D, Yebyo H, Tomonaga Y, Seiler B, Puhan M, Schwenkglenks M . Early rehabilitation in the intensive care unit: Systematic early rehabilitation versus individualized rehabilitation in patients after the stabilization phase. Swiss Medical Board. 2020. https://www.swissmedicalboard.ch/fileadmin/public/news/2020/SMB_Assessment_ICU_Early_Rehabilitation_HTA_Report_final_20200106.pdf

Bhadhuri A, Insinga R, Guggisberg P, Panje C, Schwenkglenks M. Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland. Swiss Med Wkly. 2019 Dec 27;149:w20170. doi: 10.4414/smw.2019.20170. PMID: 31880807.

Witassek F, Springer A, Adam L, Aeschbacher S, Beer JH, Blum S, Bonati LH, Conen D, Kobza R, Kühne M, Moschovitis G, Osswald S, Rodondi N, Sticherling C, Szucs T, Schwenkglenks M; Swiss-AF study investigators. Health-related quality of life in patients with atrial fibrillation: The role of symptoms, comorbidities, and the type of atrial fibrillation. PLoS One. 2019 Dec 23;14(12):e0226730. doi: 10.1371/journal.pone.0226730. PMID: 31869399; PMCID: PMC6927649.

Ilinca S, Di Giorgio L, Salari P, Chuma J. Socio-economic inequality and inequity in use of health care services in Kenya: evidence from the fourth Kenya household health expenditure and utilization survey. Int J Equity Health. 2019 Dec 18;18(1):196. doi: 10.1186/s12939-019-1106-z. PMID: 31849334; PMCID: PMC6918604.

Salari P, Di Giorgio L, Ilinca S, Chuma J.  "The catastrophic and impoverishing effects of out-of-pocket healthcare payments in Kenya, 2018." BMJ Glob Health. 2019 Nov 24;4(6):e001809. doi: 10.1136/bmjgh-2019-001809. eCollection 2019. PMID: 31803510  

Schneider R, Schur N, Reinau D, Schwenkglenks M, Meier C. Helsana Arzneimittelreport 2019.

Schmucker C, Titscher V, Braun C, Dobrescu A, Klerings I, Nussbaumer-Streit B, Gartlehner G, Meerpohl JJ, Barbier M, Tomonaga Y, Schur N, Menges D, Schwenkglenks M. Comparative effectiveness, safety, and costs of surgical versus non-surgical treatment in patients with full-thickness rotator cuff tears: a systematic review and health economic assessment. Swiss Medical Board, 2019.

Szucs TD, El Saadany T. Learning and Confirming» in Pharmaforschung und -entwicklung. Von Sackgassen und Durchbrüchen. conexus 2019; 2: 63-76. doi: 10.24445/conexus.2019.02.006. https://doi.org/10.24445/conexus.2019.02.006  

Vrinten C, Stoffel S, Dodd RH, Waller J, Lyratzopoulos Y, & von Wagner C (2019). Cancer worry frequency vs. intensity and self-reported colorectal cancer screening uptake: A population-based study. Journal of Medical Screening. December 26, 2019. doi: 10.1177/0969141319842331. https://doi.org/10.1177/0969141319842331  

Witassek F, Springer A, Adam L, Aeschbacher S, Beer JH, Blum S, Bonati LH, Conen D, Kobza R, Kühne M, Moschovitis G, Osswald S, Rodondi N, Sticherling C, Szucs T, Schwenkglenks M. Swiss-AF study investigators. Health-related quality of life in patients with atrial fibrillation: The role of symptoms, comorbidities, and the type of atrial fibrillation. December 23, 2019 PLoS One 2019; 14(12):e0226730. doi: 10.1371/journal.pone.0226730. eCollection 2019. https://doi.org/10.1371/journal.pone.0226730

Bhadhuri A, Insinga R, Guggisberg P, Panje C, Schwenkglenks M. Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland. Swiss Med Wkly 2019; 149:w20170. December 16, 2019 doi: 10.4414/smw.2019.20170. eCollection. https://doi.org/10.4414/smw.2019.20170

Bhadhuri A, Al-Janabi H, Jowett S, Jolly K. Incorporating Household Spillovers in Cost Utility Analysis: A Case Study Using Behavior Change in COPD. International journal of technology assessment in health care. 2019;35(3):212-20.

Spirk D, Sebastian T, Banyai M, Beer JH, Mazzolai L, Baldi T, Aujesky D, Hayoz D, Engelberger RP, Kaeslin T, Korte W, Escher R, Husmann M, Mollet A,Szucs TD, Kucher N. Venous Thromboembolism and Renal Impairment: Insights from the Swiss Venous Thromboembolism Registry (SWIVTER). Semin Thromb Hemost. 2019 Nov; 45(8):851-858. doi: 10.1055/s-0039-1698770. https://doi.org/10.1055/s-0039-1698770

von Wagner C, Verstraete W, & Stoffel, S (2019). Psychological aspects of cancer screening. In Oxford Research Encyclopedia of Psychology, Oxford University Press. November 2019, doi: 10.1093/acrefore/9780190236557.013.130. https://doi.org/10.1093/acrefore/9780190236557.013.130

Schneider R, Reinau D, Schur N, Blozik E, Früh M, Signorell A, Heininger U, Schwenkglenks M, Meier CR. Coverage rates and timeliness of nationally recommended vaccinations in Swiss preschool children: A descriptive analysis using claims data. Vaccine. 2019; pii: S0264-410X (19)31599-3. doi: 10.1016/j.vaccine.2019.11.057. [Epub ahead of print]. https://doi.org/10.1016/j.vaccine.2019.11.057

Sutherland CS, Ademi Z, Michaud J, Schur N, Lingg M, Bhadhuri A, Pache TD, Bitzer J, Suchon P, Albert V, Hersberger KE, Tanackovic G, Schwenkglenks M. Economic evaluation of a novel genetic screening test for risk of venous thromboembolism compared with standard of care in women considering combined hormonal contraception in Switzerland. BMJ Open 2019; 9(11):e031325. doi: 10.1136/bmjopen-2019-031325. https://doi.org/10.1136/bmjopen-2019-031325

Pillai N, Lupatsch JE, Dusheiko M, Schwenkglenks M, Maillard M, Sutherland CS, Pittet VEH. Swiss IBD Cohort study group. Evaluating the cost-effectiveness of early compared to late or no biologic treatment to manage Crohn's disease using real world data. J Crohns Colitis 2019; pii: jjz169. doi: 10.1093/ecco-jcc/jjz169. [Epub ahead of print]. https://doi.org/10.1093/ecco-jcc/jjz169

Mattli R, Farcher R, Syleouni ME, Wieser S, Probst-Hensch N, Schmidt-Trucksäss A, Schwenkglenks M. Physical Activity Interventions for Primary Prevention in Adults: A Systematic Review of Randomized Controlled Trial-Based Economic Evaluations. Sports Med 2019. doi: 10.1007/s40279-019-01233-3. [Epub ahead of print]. https://doi.org/10.1007/s40279-019-01233-3

Blum S, Aeschbacher S, Meyre P, Zwimpfer L, Reichlin T, Beer JH, Ammann P, Auricchio A, Kobza R, Erne P, Moschovitis G, Di Valentino M, Shah D, Schläpfer J, Henz S, Meyer-Zürn C, Roten L, Schwenkglenks M, Sticherling C, Kühne M, Osswald S, Conen D. Swiss‐AF Investigators. Incidence and Predictors of Atrial Fibrillation Progression. J Am Heart Assoc 2019; 8(20):e012554. doi: 10.1161/JAHA.119.012554. Epub 2019 Oct 8. https://doi.org/10.1161/JAHA.119.012554

Ghanouni A, Waller J, Stoffel ST, Vlaev I, von Wagner C. Acceptability of risk-stratified breast screening: Effect of the order of presenting risk and benefit information. Journal of Medical Screening, October 1, 2019. doi: 10.1177/096914131987766. https://doi.org/10.1177/0969141319877669

von Wagner C, Bonello B, Stoffel ST, Skrobanski H, Kerrison R, McGregor LM, L. Predictors of intention translation in flexible sigmoidoscopy screening for colorectal cancer. Health Psychology. September 26, 2019. doi: 10.1037/hea0000793. doi.org/10.1037/hea0000793 

von Wagner C, Cadar D, Hackett RA, Demakakos P, Beeken RJ, Cooper Bailey S, Wolf M, Steptoe A,  Renzi C, Stoffel ST. Type 2 diabetes and colorectal cancer screening: Findings from the English Longitudinal Study of Ageing. Journal of Medical Screening. September 23, 2019. doi: 10.1177/096914131987483. https://doi.org/10.1177/0969141319874834

Schneider R, Reinau D, Schur N, Blozik E, Früh M, Signorell A, Meier CR, Schwenkglenks M. Drug prescription patterns, polypharmacy and potentially inappropriate medication in Swiss nursing homes: a descriptive analysis based on claims data. Swiss Med Wkly 2019; 149: w20126. doi: 10.4414/smw.2019.20126. eCollection 2019 Sep 23. https://doi.org/10.4414/smw.2019.20126

Speich B, Gloy V, Schur N, Ewald H, Hemkens LG, Schwenkglenks M, Briel M: Making Randomized Trials Affordable (MARTA) Group. A scoping review shows that several nonvalidated budget planning tools for randomized trials are available. J Clin Epidemiol 2020 Jan; 117:9-19. doi: 10.1016/j.jclinepi.2019.09.009. Epub 2019 Sep 15. https://doi.org/10.1016/j.jclinepi.2019.09.009

von Wagner C, Hirst, Y, Waller J, Ghanouni A, McGregor LM, Kerrison RS, Verstraete W, Sieverding M, Stoffel ST (2019). The impact of descriptive norms on motivation to participate in cancer screening – Evidence from online experiments. Patient Education and Counseling. 0738-3991., September 2019. doi: 10.1016/j.pec.2019.04.001. https://doi.org/10.1016/j.pec.2019.04.001  

Jungo KT, Rozsnyai Z, Mantelli S, Floriani C, Löwe AL, Lindemann F, Schwab N, Meier R, Elloumi L, Huibers CJA, Sallevelt BTGM, Meulendijk MC, Reeve E, Feller M, Schneider C, Bhend H, Bürki PM, Trelle S, Spruit M, Schwenkglenks M, Rodondi N, Streit S. 'Optimising PharmacoTherapy In the multimorbid elderly in primary Care' (OPTICA) to improve medication appropriateness: study protocol of a cluster randomised controlled trial. BMJ Open 2019;9(9):e031080. doi: 10.1136/bmjopen-2019-031080. https://doi.org/10.1136/bmjopen-2019-031080

Stoffel ST, Kerrison RS, Vlaev I, von Wagner C. Offering male endoscopists as decoy option to nudge disinclined women to have colorectal cancer screening. Journal of Behavioral Medicine. August 30, 2019. doi: 10.1007/s10865-019-00095-4  https://doi.org/10.1007/s10865-019-00095-4 

Stoffel ST, Yang J, Vlaev I, von Wagner C. Correction: Testing the decoy effect to increase interest in colorectal cancer screening. PloS one, 14(3). July 10, 2019 PLoS One. 2019 Jul 10; 14(7):e0219811. doi: 10.1371/journal.pone.0219811. eCollection 2019. https://doi.org/10.1371/journal.pone.0219811

Glinz D, Gloy VL, Monsch AU, Kressig RW, Patel C, McCord KA, Ademi Z, Tomonaga Y, Schwenkglenks M, Bucher HC, Raatz H. Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis. Swiss Med Wkly 2019; 149: w20093. doi: 10.4414/ smw.2019.20093. eCollection 2019 Jun 17. https://doi.org/10.4414/smw.2019.20093

Adam L, Moutzouri E, Baumgartner C, Loewe AL, Feller M, M'Rabet-Bensalah K, Schwab N, Hossmann S, Schneider C, Jegerlehner S, Floriani C, Limacher A, Jungo KT, Huibers CJA, Streit S, Schwenkglenks M, Spruit M, Van Dorland A, Donzé J, Kearney PM, Jüni P, Aujesky D, Jansen P, Boland B, Dalleur O, Byrne S, Knol W, Spinewine A, O'Mahony D, Trelle S, Rodondi N. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial. June 3, 2019 BMJ Open 2019; 9(6):e026769. doi: 10.1136/bmjopen-2018-026769.

Stoffel ST, Goodwin M, Sieverding M, Vlaev I,von Wagner C. Testing verbal quantifiers for social norms messages: Evidence from an online experiment. BMC public health. May 29, 2019. doi: 10.1186/s12889-019-6997-5 https://doi.org/10.1186/s12889-019-6997-5  

Komann M, Weinmann C, Schwenkglenks M, Meissner W. Non-Pharmacological Methods and Post-Operative Pain Relief: An Observational Study. Anesth Pain Med 2019 Apr 20;9(2):e84674. doi: 10.5812/aapm.84674. eCollection 2019 Apr. https://doi.org/10.5812/aapm.84674

Von Wagner C, Stoffel ST, Freeman M, Laszlo HE, Nicholson B, Sheringham J, Szinay D, Hirst Y. General practitioners' awareness of the recommendations for Faecal Immunochemical Tests (FIT) for suspected lower gastrointestinal cancers: a national survey. BMJ Open. April 11, 2019. 9:e025737. doi: 10.1136/bmjopen-2018-025737. https://doi.org/10.1136/bmjopen-2018-025737

Grossmann R, Schneider MA, Linecker M, Lehn JM, Nicolau C, Traber M, Tay F, Vicente D, Jetter A, Mollet A,Szucs T, Graf R, Clavien PA, Limani P. Interprofessional and interdisciplinary collaboration for early phase oncological clinical trials in academia-Myo-inositoltrispyrophophate as model. Pharmacol Res. 2019 Apr 19:104238. doi: 10.1016/j.phrs.2019.04.022. https://doi.org/10.1016/j.phrs.2019.04.022

Sutherland CS, Tediosi F. Is the elimination of 'sleeping sickness' affordable? Who will pay the price? Assessing the financial burden for the elimination of human African trypanosomiasis Trypanosoma brucei gambiense in sub-Saharan Africa. BMJ Glob Health. 2019 Apr 14;4(2):e001173. doi: 10.1136/bmjgh-2018-001173. eCollection 2019. PMID: 31139437. https://doi.org/10.1136/bmjgh-2018-001173.

Ulyte A, Bähler C, Schwenkglenks M, von Wyl V, Gruebner O, Wei W, Blozik E, Brüngger B, Dressel H. Measuring diabetes guideline adherence with claims data: systematic construction of indicators and related challenges. April 24, 2019 BMJ Open 2019; 9(4):e027138. doi: 10.1136/bmjopen-2018-027138. https://doi.org/10.1136/bmjopen-2018-027138

Conen D, Rodondi N, Müller A, Beer JH, Ammann P, Moschovitis G, Auricchio A, Hayoz D, Kobza R, Shah D, Novak J, Schläpfer J, Di Valentino M, Aeschbacher S, Blum S, Meyre P, Sticherling C, Bonati LH, Ehret G, Moutzouri E, Fischer U, Monsch AU, Stippich C, Wuerfel J, Sinnecker T, Coslovsky M, Schwenkglenks M, Kühne M, Osswald S; Swiss-AF Study Investigators. Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation. J Am Coll Cardiol March 12, 2019; 73:989-999. doi: 10.1016/j.jacc.2018.12.039. https://doi.org/10.1016/j.jacc.2018.12.039

Warren E, Morgan K, Toward TJ, Schwenkglenks M, Leadbetter J. Cost Effectiveness of Inhaled Mannitol (Bronchitol^®) in Patients with Cystic Fibrosis. Pharmacoeconomics. March 2019; 37:435-46. doi: 10.1007/s40273-019-00767-8. https://doi.org/10.1007/s40273-019-00767-8

Blank PR, Tomonaga Y, Szucs TD, Schwenkglenks M. Economic burden of symptomatic iron deficiency - a survey among Swiss women. BMC Women’s Health. February 26, 2019; 19(1):39. doi: 10.1186/s12905-019-0733-2. https://doi.org/10.1186/s12905-019-0733-2

Stoffel S, Benito L, Milà N, Travier N, Binefa G, Vidal C,Espinosa J, Moreno V, Garcia M Testing behavioural interventions to optimize participation in a population-based colorectal cancer screening program in Catalonia, Spain. Preventive medicine, February 2019; 119, 58-62 https://doi.org/10.1016/j.ypmed.2018.12.013

Mattli R, Wieser S, Probst-Hensch N, Schmidt-Trucksäss A, Schwenkglenks M. Physical inactivity caused economic burden depends on regional cultural differences. Scand J Med Sci Sports. January 29, 2019; 29:95-104. doi: 10.1111/sms.13311. https://doi.org/10.1111/sms.13311

Speich B, Schur N, Gryaznov D, von Niederhäusern B, Hemkens LG, Schandelmaier S, Amstutz A, Kasenda B, Pauli-Magnus C, Ojeda-Ruiz E, Tomonaga Y, McCord K, Nordmann A, von Elm E, Briel M*, Schwenkglenks M*. A collaboration of the MARTA (MAking Randomized Trials Affordable) and ASPIRE (Adherence to Standard Protocol Items: REcommendations for interventional trials) Study Groups. Resource use, costs, and approval times for planning and preparing a randomized clinical trial before and after the implementation of the new Swiss human research legislation. PLoS One January 11, 2019; 14(1):e0210669. doi: 10.1371/journal.pone.0210669. [Epub]. https://doi.org/10.1371/journal.pone.0210669
* Shared last authorship.

Schneider R, Schur N, Reinau D, Gut S, Schwenkglenks M, Meier C. Helsana Arzneimittelreport 2018.

Barbier M, Tomonaga Y, Schwenkglenks M. Robot-assisted surgery in women undergoing hysterectomy / Robotic-assisted radical prostatectomy compared to open radical prostatectomy for the treatment of localised prostate cancer. Swiss Medical Board, 2018

Romanens M, Szucs T, Sudano I, Adams A. Agreement of PROCAM and SCORE to assess cardiovascular risk in two different low risk European populations.Prev Med Rep. 2018 Dec 1;13:113-117

Hirschmann A, Lupatsch JE, Schwenkglenks M, Panje CM, Matter-Walstra K, Espeli V, Dedes KJ, Siano M; Swiss Group of Clinical Cancer Research (SAKK). Cost-effectiveness of nivolumab in the treatment of head and neck cancer. Oral Oncol. 2018 Dec;87:104-110

Schmidt H, Caldwell B, Mollet A, Leimer HG, Szucs T. An Industry Experience with Data Sharing. N Engl J Med. 2018 Nov 22;379(21):2081-2082

Wei W, Gruebner O, von Wyl V, Brüngger B, Dressel H, Ulyte A, Blozik E, Bähler C, Schwenkglenks M. Variation of preoperative chest radiography utilization in Switzerland and its influencing factors: a multilevel study with claims data. Sci Rep. 2018 Nov 30;8(1):17475

Kreis C, Doessegger E, Lupatsch JE, Spycher BD. Space-time clustering of childhood cancers: a systematic review and pooled analysis. Eur J Epidemiol. 2019 Jan;34(1):9-21

Griese-Mammen N, Hersberger KE, Messerli M, Leikola S, Horvat N, van Mil JWF, Kos M. PCNE definition of medication review: reaching agreement. Int J Clin Pharm. 2018 Oct;40(5):1199-1208

Mazzonna F, Salari P. Can a smoking ban save your heart?Health Econ. 2018 Oct;27(10):1435-1449

Tlhajoane M, Masoka T, Mpandaguta E, Rhead R, Church K, Wringe A, Kadzura N, Arinaminpathy N, Nyamukapa C, Schur N, Mugurungi O, Skovdal M, Eaton JW, Gregson S. A longitudinal review of national HIV policy and progress made in health facility implementation in Eastern Zimbabwe. Health Res Policy Syst. 2018 Sep 21;16(1):92

Mattli R, Wieser S, Probst-Hensch N, Schmidt-Trucksäss A, Schwenkglenks M. Physical inactivity caused economic burden depends on regional cultural differences. Scand J Med Sci Sports. 2019 Jan;29(1):95-104.

Lupatsch JE, Kreis C, Korten I, Latzin P, Frey U, Kuehni CE, Spycher BD. Neighbourhood child population density as a proxy measure for exposure to respiratory infections in the first year of life: A validation study.PLoS One. 2018 Sep 12;13(9):e0203743

Weber WP, Tausch C, Hayoz S, Fehr MK, Ribi K, Hawle H, Lupatsch JE, Matter-Walstra K, Chiesa F, Dedes KJ, Berclaz G, Lelièvre L, Hess T, Güth U, Pioch V, Sarlos D, Leo C, Canonica C, Gabriel N, Zeindler J, Cassoly E, Andrieu C, Soysal SD, Ruhstaller T, Fehr PM, Knauer M; Swiss Group for Clinical Cancer Research (SAKK). Impact of a Surgical Sealing Patch on Lymphatic Drainage After Axillary Dissection for Breast Cancer: The SAKK 23/13 Multicenter Randomized Phase III Trial. Ann Surg Oncol. 2018 Sep;25(9):2632-2640

Schur N, Brugaletta S, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Valgimigli M, Serruys PW, Ademi Z, Schwenkglenks M, Sabaté M. Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial. PLoS One. 2018 Aug 16;13(8):e0201985

Panje CM, Dedes KJ, Matter-Walstra K, Schwenkglenks M, Gautschi O, Siano M, Aebersold DM, Plasswilm L, Lupatsch JE; Swiss Group for Clinical Cancer Research (SAKK). A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC). Radiother Oncol. 2018 Nov;129(2):257-263

Muehlematter UJ, Nagel HW, Becker A, Mueller J, Vokinger KN, de Galiza Barbosa F, Ter Voert EEGT, Veit-Haibach P, Burger IA. Impact of time-of-flight PET on quantification accuracy and lesion detection in simultaneous 18F-choline PET/MRI for prostate cancer. EJNMMI Res. 2018 May 31;8(1):41

Sheikh S, Biundo E, Courcier S, Damm O, Launay O, Maes E, Marcos C, Matthews S, Meijer C, Poscia A, Postma M, Saka O, Szucs T, Begg N. A report on the status of vaccination in Europe. Vaccine. 2018 Aug 9;36(33):4979-4992

Leon-Reyes S, Schäfer J, Früh M, Schwenkglenks M, Reich O, Schmidlin K, Staehelin C, Battegay M, Cavassini M, Hasse B, Bernasconi E, Calmy A, Hoffmann M, Schoeni-Affolter F, Zhao H, Bucher HC. Cost Estimates for Human Immunodeficiency Virus (HIV) Care and Patient Characteristics for Health Resource Use From Linkage of Claims Data With the Swiss HIV Cohort Study. Clin Infect Dis. 2019 Feb 15;68(5):827-833

Ademi Z, Tomonaga Y, van Stiphout J, Glinz D, Gloy V, Raatz H, Bucher HC, Schwenkglenks M. Adaptation of cost-effectiveness analyses to a single country: the case of bariatric surgery for obesity and overweight. Swiss Med Wkly. 2018 Jun 12;148:w14626

Merritt MW, Sutherland CS, Tediosi F.EthicalConsiderations for Global Health Decision-Making: Justice-Enhanced Cost-Effectiveness Analysis of New Technologies for Trypanosoma brucei gambiense. Public Health Ethics. 2018 Jul 18;11(3):275-292

Tomonaga Y, Ten Haaf K, Frauenfelder T, Kohler M, Kouyos RD, Shilaih M, Lorez M, de Koning HJ, Schwenkglenks M, Puhan MA. Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling study. Lung Cancer. 2018 Jul;121:61-69

Szucs TD, Szillat KP, Blozik E. Budget impact model for oncopharmacogenetics from the perspective of mandatory basic health insurance in Switzerland using the example of breast cancer. Pharmgenomics Pers Med. 2018 Apr 23;11:67-69

Keller F, Dhaini S, Briel M, Henrichs S, Höchsmann C, Kalbermatten D, Künzli N, Mollet A, Puelacher C, Schmidt-Trucksäss A, von Niederhäusern B, De Geest S. How to Conceptualize and Implement a PhD Program in Health Sciences-The Basel Approach. J Med Educ Curric Dev. 2018 Apr 24;5:2382120518771364

Moehrlen T, Szucs T, Landolt MA, Meuli M, Schiestl C, Moehrlen U. Trauma mechanisms and injury patterns in pediatric burn patients. Burns. 2018 Mar;44(2):326-334

Wieser S, Riguzzi M, Pletscher M, Huber CA, Telser H, Schwenkglenks M. How much does the treatment of each major disease cost? A decomposition of Swiss National Health Accounts. Eur J Health Econ. 2018 Nov;19(8):1149-1161

Reinau D, Schwenkglenks M, Früh M, Signorell A, Blozik E, Meier CR. Glucocorticoids and the Risk of Peptic Ulcer Bleeding: Case-Control Analysis Based on Swiss Claims Data. Drug Saf. 2018 Jul;41(7):725-730

Speich B, von Niederhäusern B, Blum CA, Keiser J, Schur N, Fürst T, Kasenda B, Christ-Crain M, Hemkens LG, Pauli-Magnus C, Schwenkglenks M, Briel M; MAking Randomized Trials Affordable (MARTA) Group. Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list. J Clin Epidemiol. 2018 Apr;96:73-83

Speich B, von Niederhäusern B, Schur N, Hemkens LG, Fürst T, Bhatnagar N, Alturki R, Agarwal A, Kasenda B, Pauli-Magnus C, Schwenkglenks M, Briel M1; MAking Randomized Trials Affordable (MARTA) Group. Systematic review on costs and resource use of randomized clinical trials shows a lack of transparent and comprehensive data. J Clin Epidemiol. 2018 Apr;96:1-11

Fürst T, Salari P, Llamas LM, Steinmann P, Fitzpatrick C, Tediosi F. Global health policy and neglected tropical diseases: Then, now, and in the years to come. PLoS Negl Trop Dis. 2017 Sep 14;11(9):e0005759.

Vokinger KN, Kesselheim AS, Avorn J, Sarpatwari A. Strategies That Delay Market Entry of Generic Drugs. JAMA Intern Med. 2017 Nov 1;177(11):1665-1669

Schneider R, Schur N, Reinau D, Schwenkglenks M, Meier C. Helsana Arzneimittelreport 2017.

Kastien-Hilka T, Rosenkranz B, Schwenkglenks M, et al. Association between Health-Related Quality of Life and Medication Adherence in Pulmonary Tuberculosis in South Africa. Front Pharmacol. 2017 Dec 18; 8:919

Speich B, von Niederhäusern B, Blum CA, et al (including Schwenkglenks M). Randomized Trials Affordable (MARTA) Group. Retrospective assessment of resource use and costs in two investigator-initiated randomised trials exemplified a comprehensive cost item list. J Clin Epidemiol. 2017 Dec 29

Speich B, von Niederhäusern B, Schur N, et al (including Schwenkglenks M). Randomized Trials Affordable (MARTA) Group. Systematic review on costs and resource use of randomised clinical trials shows a lack of transparent and comprehensive data. J Clin Epidemiol. 2017 Dec 26.

Ademi Z, Pfeil AM, Hancock E, et al (including Schwenkglenks M). Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction. Swiss Med Wkly. 2017 Nov

Ademi Z, Sutherland CS, Van Stiphout J, Michaud J, Tanackovic G, Schwenkglenks. M. A systematic review of cost-effectiveness analysis of screening interventions for assessing the risk of venous thromboembolism in women considering combinedoral contraceptives. J Thromb Thrombolysis. 2017 Nov;44(4):494-506.

Conen D, Rodondi N, Mueller A, et al (including Schwenkglenks M). Design of the Swiss Atrial Fibrillation Cohort Study (Swiss-AF): structural brain damage and cognitive decline among patients with atrial fibrillation. Swiss Med Wkly. 2017 Jul

Blank PR, Ademi Z, Lu X, Szucs TD, Schwenkglenks M. Herpes zoster vaccine: A health economic evaluation for Switzerland. Hum Vaccin Immunother. 2017 Jul 3;13(7):1495-1504.

Kastien-Hilka T, Rosenkranz B, Sinanovic, et al (including Schwenkglenks M). Health-related quality of life in South African patients with pulmonary tuberculosis. PLoS One. 2017 Apr 20; 12(4)

Schandelmaier S, Tomonaga Y, Bassler D, et al (including Schwenkglenks M). remature Discontinuation of Pediatric Randomized Controlled Trials: A Retrospective Cohort Study. J Pediatr. 2017 May; 184:209-214.e1.

Matter-Walstra K, Schwenkglenks M, Dedes KJ. Cost-effectiveness of palbociclib plus letrozole versus letrozole alone as a first-line treatment in women with oestrogen receptor-positive, HER2-negative, advanced breast cancer. Revised results for the Swiss health care setting. Breast Cancer Res Treat. 2017 Jun;163(3):635

Biétry FA, Pfeil AM, Reich O, Schwenkglenks M, et al. Benzodiazepine Use and Risk of Developing Alzheimer's Disease: A Case-Control Study Based on Swiss Claims Data. CNS Drugs. 2017 Mar;31(3):245-251.

Aichmair A, Burgstaller JM, Schwenkglenks M et al.; LSOS Study Group. Cost-effectiveness of conservative versus surgical treatment strategies of lumbar spinal stenosis in the Swiss setting: analysis of the prospective multicenter Lumbar Stenosis Outcome Study (LSOS). Eur Spine J. 2017 Feb;26(2):501-509.

Schmutz C, Mäusezahl D, Bless PJ, et al (including Schwenkglenks M). Estimating healthcare costs of acute gastroenteritis and human campylobacteriosis in Switzerland. Epidemiol Infect. 2017 Mar;145(4):627-641.

Matter-Walstra KW, Achermann R, Rapold R, et al (including Schwenkglenks M and Szucs TD) Days spent in acute care hospitals at the end of life of cancer patients in four Swiss cantons: a retrospective database study (SAKK 89/09). Eur J Cancer Care (Engl). 2017 Jul;26(4).

Gautschi O, Rothschild SI, Li Q, Matter-Walstra, et al. Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial. Clin Lung Cancer. 2017 May;18(3):303-309.

Ademi Z, Pasupathi K, Liew D. Clinical and Cost Effectiveness of Apixaban Compared to Aspirin in Patients with Atrial Fibrillation: An Australian Perspective. Appl Health Econ Health Policy. 2017 Jun;15(3):363-374.

Blank PR, Szucs TD. Sozialer und ökonomischer Nutzen der Impfung gegen Influenza. Praxis (Bern 1994). 2017;106(11):589-593.

Jain AB, Mollet A, Szucs TD. Regulatory watch: Structural and procedural characteristics of international regulatory authorities. Nat Rev Drug Discov. 2017 Sep;16(9):594.

Szucs TD, Weiss M, Klaus G. The enigma of value: in search of affordable and accessible health care. Eur J Health Econ. 2017 Jul;18(6):667-670.

Sutherland CS, Stone CM, Steinmann P, et al. Seeing beyond 2020: an economic evaluation of contemporary and emerging strategies for elimination of Trypanosoma brucei gambiense. Lancet Glob Health. 2017 Jan;5(1): e69-e79.

Biétry F, Schur N, Reinau D, Becker C, Schwenkglenks M, Meier C. Helsana Arzneimittelreport 2016.

Matter-Walstra K, Schwenkglenks M, Aebi S, et al. A Cost-Effectiveness Analysis of Nivolumab  versus Docetaxel for Advanced Nonsquamous NSCLC Including PD-L1 Testing. J Thorac Oncol. 2016;11(11):1846-1855.

Matter-Walstra K, Ruhstaller T, Klingbiel D, et al. Palbociclib as a first-line treatment in oestrogen receptor-positive, HER2-negative, advanced breast cancer not cost-effective with current pricing:  a health economic analysis of the Swiss Group for Clinical Cancer Research (SAKK). Breast Cancer  Res Treat. 2016;158(1):51-7.

Matter-Walstra K, Braun R, Kolb C, et al. Treatment specific utility-weightings are needed for cost-utility analysis in metastatic melanoma: reply from the authors. Br J Dermatol. 2016;174(2):463.

Matter-Walstra K, Schwenkglenks M, Betticher D, et al. Bevacizumab Continuation Versus

Treatment Holidays After First-Line Chemotherapy With Bevacizumab in Patients With Metastatic Colorectal Cancer: A Health Economic Analysis of a Randomized Phase 3 Trial (SAKK 41/06).  Clin Colorectal Cancer. 2016;15(4):314-320.e2.

Matter-Walstra K, Ademi Z. Understanding literature-based health economic analyses in oncology. Schweizerisches Krebsbulletin. 2016;4:327.

Gautschi O, Li Q, Matter-Walstra K, Betticher D, et al. 143PD: Bevacizumab and pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous NSCLC:  Results of the expanded SAKK19/09 trial. J Thorac Oncol. 2016;11(4 Suppl):S120.

Rochlitz C, Bigler M, von Moos R, et al (including Matter-Walstra K). SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer  – a multicenter, randomized phase III trial. BMC Cancer. 2016;16(1):780.

Schwenkglenks M, Matter-Walstra K. Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments. Expert Rev Pharmacoecon Outcomes Res. 2016;16(2):207-19.

Schandelmaier S, Conen K, von Elm E, et al (including Schwenkglenks M). Planning and reporting of quality-of-life outcomes in cancer trials. Ann Oncol. 2016;27(1):209.

Biétry FA, Reich O, Schwenkglenks M, et al. Statin use and risk of cholecystectomy – A case-control analysis using Swiss claims data. Expert Opin Drug Saf. 2016;15(12):1577-1582.

Kastien-Hilka T, Abulfathi A, Rosenkranz B, et al (including Schwenkglenks M). Health-related  quality of life and its association with medication adherence in active pulmonary tuberculosis-  a systematic review of global literature with focus on South Africa. Health Qual Life Outcomes. 2016;14:42.

Kasenda B, von Elm E, You JJ, et al (including Schwenkglenks M). Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials. PLoS Med. 2016;13(6):e1002046.

Schandelmaier S, von Elm E, You JJ, et al (including Schwenkglenks M). Premature Discontinuation of Randomized Trials in Critical and Emergency Care: A Retrospective Cohort Study. Crit Care Med. 2016;44(1):130-7.

Kastien-Hilka T, Rosenkranz B, Bennett B, et al (including Schwenkglenks M). How to Evaluate Health-Related Quality of Life and Its Association with Medication Adherence in Pulmonary Tuberculosis – Designing a Prospective Observational Study in South Africa. Front Pharmacol. 2016;7:125.

Ademi Z, Gloy V, Glinz D, et al. Cost-effectiveness of primarily surgical versus primarily conservative treatment of acute and subacute radiculopathies due to intervertebral disc herniation from the Swiss perspective. Swiss Med Wkly. 2016;146:w14382.

Ademi Z, Pasupathi K, Liew D. Cost-Effectiveness of Eplerenone Compared to Usual Care in Patients With Chronic Heart Failure and NYHA Class II Symptoms, an Australian Perspective. Medicine (Baltimore). 2016;95(18):e3531.

Burton NW, Ademi Z, Best S, et al. Efficacy of brief behavioral counselling by allied health professionals to promote physical activity in people with peripheral arterial disease (BIPP): study protocol for a multi-center randomized controlled trial. BMC Public Health. 2016;16(1):1148.

Collaborators (769) including Ademi Z, Global, regional, and national life expectancy, all-cause  mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459-1544.

Collaborators (630) including Ademi Z, Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545-1602

Collaborators (644) including Ademi Z, Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks,  1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1659-1724.

Szucs TD, Stoffel AW. Nutrition and health – Why payors should get involved. Nutrition. 2016;32(5):615-6.

Risch M, Risch L, Purde MT, Renz H, et al (including Szucs TD). Association of the cystatin  C/creatinine ratio with the renally cleared hormones parathyroid hormone (PTH) and brain natriuretic peptide (BNP) in primary care patients: a cross-sectional study. Scandinavian Journal of Clinical and Laboratory Investigation. 2016.

Grous P, Anchisi S, Szucs TD. Cancer patient’s contribution to reduce chemotherapy related burden of travel: what would chemotherapy patients agree to do? Open Public Health Journal 2016.

Szucs TD, Blozik E, Reich O. Die moderne Psychiatrie im Spannungsfeld zwischen Machbarkeit und Finanzierbarkeit. Swiss Archives of Neurology and Psychiatry. 2016;167(06):177-183.

Bräm C, Szucs TD. Is It Desirable that I Must Disclose My Genetic Data to Swiss Private Medical Insurances? Public Health Genomics. 2016;19(5):251-9.

Szucs TD, Weiss M, Klaus G. The enigma of value: in search of affordable and accessible  health care. Eur J Health Econ. 2016 Dec 2.

Biétry F, Schur N, Pfeil A, Schwenkglenks M, Meier C. Helsana Arzneimittelreport 2015.

Jürgens V, Ess S, Schwenkglenks M, et al. Using lung cancer mortality to indirectly approximate smoking patterns in space. Spat Spatiotemporal Epidemiol. 2015 Jul-Oct; 14-15:23-31. Epub 2015 Jul 1.

Schandelmaier S, Conen K, von Elm E, et al. Schwenkglenks M. Planning and reporting of quality-of-life outcomes in cancer trials. Ann Oncol. 2015 Sep; 26(9):1966-73. Epub 2015 Jun 30. Erratum in: Ann Oncol. 2016 Jan; 27(1):209.

Blank PR, Filipits M, Dubsky P, et al. Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients. Pharmacoeconomics. 2015 Feb;33(2):179-90.

Belleli R, Fisch R, Szucs TD. Regulatory watch: Efficiency indicators for new drugs approved by the FDA from 2003 to 2013. Nat Rev Drug Discov. 2015 Mar;14(3):156.

Pfeil AM, Reich O, Guerra IM, Cure S, et al. Cost-effectiveness analysis of sofosbuvir compared to current standard treatment in Swiss patients with chronic hepatitis C. PLoS One. 2015 May 14;10(5).

Pfeil AM, Allcott K, Pettengell R, et al. Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review. Support Care Cancer. 2015 Feb; 23(2):525-45. Epub 2014 Oct 7.

Pfeil AM, Imfeld P, Pettengell R, et al. Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD). Ann Hematol. 2015 Mar; 94(3):421-9. Epub 2014 Sep 16.

Gutzwiller FS, Pfeil AM, Ademi Z, et al. Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland. Pharmacoeconomics. 2015 Dec; 33(12):1311-24.

Vulsteke C, Pfeil AM, Maggen C, Schwenkglenks M et al. Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients. Breast Cancer Res Treat. 2015 Jul; 152(1):67-76. Epub 2015 May 28.

Vulsteke C, Pfeil AM, Schwenkglenks M, et al. Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. Breast Cancer Res Treat. 2014 Oct; 147(3):557-70. Epub 2014 Aug.

Matter-Walstra K, Braun R, Kolb C, et al. A cost-effectiveness analysis of trametinib plus dabrafenib as first-line therapy for metastatic BRAF V600-mutated melanoma in the Swiss setting. Br J Dermatol. 2015 Dec; 173(6):1462-70. Epub 2015 Nov 7.

Matter-Walstra KW, Achermann R, Rapold R, et al. Cancer-related therapies at the end of life in hospitalized cancer patients from four Swiss cantons: SAKK 89/09. Oncology. 2015; 88(1):18-27. Epub 2014 Sep 26.

Kovacević A, Dragojević-Simić V, Rancić N, et al. Matter-Walstra K.  End-of-life costs of medical care for advanced stage cancer patients.Vojnosanit Pregl. 2015 Apr; 72(4):334-41.

Matter-Walstra KW, Greiner M, Cusini A, et al. Stringent adherence to a cytomegalovirus-prevention protocol is associated with reduced overall costs in the first 6 months after kidney transplantation. Transpl Infect Dis. 2015 Jun;17(3):342-9. Epub 2015 May 19.

Chowdhury E, Ademi Z, Moss J, et al. 4B.04: COST-UTILITY OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR COMPARED TO THIAZIDE DIURETIC -BASED TREATMENT FOR HYPERTENSION IN ELDERLY AUSTRALIANS CONSIDERING DIABETES AS COMORBIDITY. J Hypertens. 2015 Jun; 33 Suppl 1:e53-7.

Chowdhury EK, Langham RG, Ademi Z, et al; Second Australian National Blood Pressure Study Management Committee. Rate of change in renal function and mortality in elderly treated hypertensive patients. Clin J Am Soc Nephrol. 2015 Jul 7; 10(7):1154-61. Epub 2015 Apr 21.

Chowdhury EK, Ademi Z, Moss JR et al; Second Australian National Blood Pressure Study Management Committee. Cost-utility of angiotensin-converting enzyme inhibitor-based treatment compared with thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidity. Medicine (Baltimore). 2015 Mar; 94(9):e590.

Feigin VL, Mensah GA, Norrving B, et al; GBD 2013 Stroke Panel Experts Group including Ademi Z. Atlas of the Global Burden of Stroke (1990-2013): The GBD 2013 Study. Neuroepidemiology. 2015; 45(3):230-6. Epub 2015 Oct 28.

Barker-Collo S, Bennett DA, Krishnamurthi RV, et al; GBD 2013 Writing Group; GBD 2013 Stroke Panel Experts Group including Ademi Z. Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years: Results from the Global Burden of Disease Study 2013. Neuroepidemiology. 2015; 45(3):203-14. Epub 2015 Oct 28.

Krishnamurthi RV, Moran AE, Feigin VL, et al; GBD 2013 Stroke Panel Experts Group including Ademi Z. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Adults Aged 20-64 Years in 1990-2013: Data from the Global Burden of Disease 2013 Study. Neuroepidemiology. 2015; 45(3):190-202. Epub 2015 Oct 28.

Krishnamurthi RV, deVeber G, Feigin VL, et al; GBD 2013 Stroke Panel Experts Group Including Ademi Z. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Children and Youth Aged 0-19 Years: Data from the Global and Regional Burden of Stroke 2013. Neuroepidemiology. 2015;45(3):177-89. Epub 2015 Oct 28.

Feigin VL, Krishnamurthi RV, Parmar P, et al; GBD 2013 Writing Group; GBD 2013 Stroke Panel Experts Group including Ademi Z.Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study. Neuroepidemiology. 2015; 45(3):161-76. Epub 2015 Oct 28.

GBD 2013 DALYs and HALE Collaborators including Ademi Z. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. 2015 Nov 28; 386(10009):2145-91. Epub 2015 Aug 28.

GBD 2013 Mortality and Causes of Death Collaborators includingAdemi Z. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Jan 10;385(9963):117-71. Epub 2014 Dec 18.